<SEC-DOCUMENT>0001628908-23-000175.txt : 20231103
<SEC-HEADER>0001628908-23-000175.hdr.sgml : 20231103
<ACCEPTANCE-DATETIME>20231103085353
ACCESSION NUMBER:		0001628908-23-000175
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20231103
DATE AS OF CHANGE:		20231103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evolent Health, Inc.
		CENTRAL INDEX KEY:			0001628908
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		IRS NUMBER:				320454912
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266495
		FILM NUMBER:		231374619

	BUSINESS ADDRESS:	
		STREET 1:		800 NORTH GLEBE RD, SUITE 500
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22203
		BUSINESS PHONE:		571-389-6000

	MAIL ADDRESS:	
		STREET 1:		800 NORTH GLEBE RD, SUITE 500
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22203
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>fidelityprospectussuppleme.htm
<DESCRIPTION>424B7 FIDELITY
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1f6bdbdece6446dca24b928102f9dfe8_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filed Pursuant to Rule 424(b)(7)<br>Registration No. 333-266495</font></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prospectus supplement </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(To Prospectus dated August 3, 2022) </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">8,474,576 shares </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><img alt="image_0.jpg" src="image_0.jpg" style="height:102px;margin-bottom:5pt;vertical-align:text-bottom;width:345px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">Evolent Health, Inc. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Class A common stock </font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement relates to the resale from time to time of up to 8,474,576 shares of Class A common stock of Evolent Health, Inc., par value $0.01 per share, held by the selling stockholders identified in this prospectus supplement. We are not selling any of shares of our Class A common stock pursuant to this prospectus supplement and will not receive any proceeds from the sale of shares offered by the selling stockholders. </font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders or any of their successors may sell shares of our Class A common stock directly or alternatively through underwriters, broker-dealers or agents they select and in one or more public or private transactions at market prices prevailing at the time of sale, at fixed prices, at negotiated prices, at various prices determined at the time of sale or at prices related to prevailing market prices, as further described herein. If the shares are sold through underwriters, broker-dealers or agents, the selling stockholders or purchasers of the stock will be responsible for underwriting discounts or commissions and broker-dealers&#8217; or agents&#8217; commissions. The timing and amount of any sale is within the sole discretion of the selling stockholders, subject to certain restrictions. For more information regarding the sales of shares by the selling stockholders pursuant to this prospectus supplement, please read &#8220;Plan of Distribution&#8221;. </font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A common stock is traded on the New York Stock Exchange under the symbol &#8220;EVH.&#8221; The last reported closing sale price of our Class A common stock on November 2, 2023 was $24.01 per share.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our Class A common stock involves risks. You should carefully read and consider the &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; section on page S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">8</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> of this prospectus supplement before investing in our Class A common stock. </font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus are truthful or complete. Any representation to the contrary is a criminal offense. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prospectus supplement dated November 3, 2023. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of contents</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prospectus Supplement</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.971%"><tr><td style="width:1.0%"></td><td style="width:93.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">About </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">T</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">his </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">P</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">rospectus </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">S</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">upplement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_154" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Special </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">N</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ote </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">R</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">egarding </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">F</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">orward-</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">L</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ooking </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">S</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">tatements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Where </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Y</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ou </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">C</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">an </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">F</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ind </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">M</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ore </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">I</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">nformation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_170" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Incorporation by </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">R</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">eference</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Summary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Risk Factors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_205" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Use of </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_205" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">P</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_205" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">roceeds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_205" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_225" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Selling Stockholders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_225" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_246" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Plan of </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_246" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">D</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_246" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">istribution</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_246" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_265" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Legal </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_265" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">M</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_265" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">atters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_265" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_309" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:2.77pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">S-</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_309" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">16</a></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prospectus </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.971%"><tr><td style="width:1.0%"></td><td style="width:92.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_358" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">About this</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_358" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"> P</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_358" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">rospectus</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_364" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Risk </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_364" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">F</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_364" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">actors</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Cautionary </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">S</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">tatement </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">R</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">egarding </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">F</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">orward-</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">L</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">ooking </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">S</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_368" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">tatements</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_372" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Where You Can Find More Information</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_376" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Incorporation by Reference</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_380" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">About Us</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">4</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_384" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Use of </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_384" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">P</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_384" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">roceeds</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_388" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Selling Stockholders</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_392" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Description of Class A Common Stock</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">7</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_396" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Plan of </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_396" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">D</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_396" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">istribution</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_400" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Legal </a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_400" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">M</a><a href="#i1f6bdbdece6446dca24b928102f9dfe8_400" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">atters</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_404" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">15</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neither we nor the selling stockholders have authorized anyone to provide any information other than that contained or incorporated by reference in this prospectus supplement, the accompanying prospectus or in any free writing prospectus prepared by or on behalf of us or the selling stockholders or to which we have referred you. Neither we nor the selling stockholders take responsibility for, or can provide assurance as to the reliability of, any other information that others may give you. This prospectus supplement and the accompanying prospectus is an offer to sell only the Class A common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus or any document incorporated by reference herein or therein is current only as of its date. Our business, financial condition, results of operations and prospectus may have changed since that date. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No action is being taken in any jurisdiction outside the United States to permit a public offering of our Class A common stock or possession or distribution of this prospectus supplement in that jurisdiction. Persons who come into possession of this prospectus supplement in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus supplement applicable to that jurisdiction. </font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_321"></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-i</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_154"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABOUT THIS PROSPECTUS SUPPLEMENT</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of the offering. The second part is the accompanying prospectus, which describes more general information, some of which may not apply to the offering. You should read both this prospectus supplement and the accompanying prospectus, together with additional information described under the headings &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation by Reference&#8221; in this prospectus supplement. To the extent there is a conflict between the information contained in this prospectus supplement and the information contained in the accompanying prospectus or the information contained in any document incorporated by reference herein or therein, you should rely on the information in this prospectus supplement. In addition, any statement in a filing we make with the Securities and Exchange Commission (the &#8220;SEC&#8221;), that adds to, updates or changes information contained in an earlier filing we made with the SEC shall be deemed to modify and supersede such information in the earlier filing. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated or required by the context, references in this prospectus supplement to &#8220;Evolent,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;the Company&#8221; and &#8220;our Company&#8221; refer to Evolent Health, Inc., a Delaware corporation, together with its consolidated subsidiaries. Evolent Health LLC, (&#8220;EVH LLC&#8221;) a subsidiary of Evolent Health, Inc. through which we conduct our operations, has owned all of our operating assets and substantially all of our business since inception. Evolent Health, Inc. is a holding company and its principal asset is all of the Class A common units of EVH LLC. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the accompanying prospectus dated August 3, 2022 are part of the Registration Statement (Registration No. 333-266495) that we filed with the SEC on August 3, 2022, using an automatic &#8220;shelf&#8221; registration process. This prospectus supplement relates to the offering and sale of shares of our Class A common stock by the selling stockholders from time to time. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-ii</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements made in this prospectus supplement and the accompanying prospectus and the documents incorporated herein and therein by reference and in other written or oral statements made by us or on our behalf are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like&#58; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;aim,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;shall,&#8221; &#8220;may,&#8221; &#8220;might&#8221; and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to our ability to grow our impact significantly throughout this year and beyond, future actions, trends in our businesses, prospective services, new partner additions&#47;expansions, the adoption and launch of a unified brand, our guidance and business outlook and future performance or financial results, and the closing of pending transactions and the outcome of contingencies, such as legal proceedings. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements involve risks and uncertainties that may cause actual results, level of activity, performance or achievements to differ materially from the results contained in the forward-looking statements. Risks and uncertainties that may cause actual results to vary materially, some of which are described within the forward-looking statements, include, among others&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks relating to our ability to efficiently integrate National Imaging Associates, Inc., and certain assets held by Magellan Health, Inc., and&#47;or certain of its subsidiaries used in the Magellan Specialty Health Division (&#8220;NIA&#8221;) into our operations&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the financial information of NIA and the pro forma financial information of NIA may not be indicative of future results or our financial condition&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the significant portion of revenue we derive from our largest partners, and the potential loss, non-renewal, termination or renegotiation of our relationship or contract with any significant partner, or multiple partners in the aggregate&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to terminate certain leases and recognize impairment charges in connection with our repositioning plan&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">evolution of the healthcare regulatory and political framework&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">uncertainty in the health care regulatory framework, including the potential impact of policy changes&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to offer new and innovative products and services and our ability to keep pace with industry standards, technology and our partners&#8217; needs&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks related to completed and future acquisitions, investments, alliances and joint ventures, including our acquisitions of Implantable Provider Group, Inc.  and NIA, which could divert management resources, result in unanticipated costs or dilute our stockholders&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the financial benefits we expect to receive as a result of the sale of certain assets of Justify Holdings, Inc., a wholly-owned subsidiary of the Company (&#34;Passport&#34;) to Molina Healthcare, Inc. may not be realized&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the growth and success of our partners and certain revenues from our engagements, which are difficult to predict and are subject to factors outside of our control, including governmental funding reductions and other policy changes&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks relating to our ability to maintain profitability for our total cost of care and NCIS Holdings, Inc.'s (&#34;New Century Health&#34;) performance-based contracts and products, including capitation and risk-bearing contracts&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to effectively manage our growth and maintain an efficient cost structure, and to successfully implement cost cutting measures&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in general economic conditions nationally and regionally in our markets, including increasing inflationary pressures and economic and business conditions and the impact thereof on the economy resulting from public health emergencies, epidemics, pandemics or contagious diseases such as the COVID-19 pandemic&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks related to the failure of any bank in which we deposit our funds, which could reduce the amount of cash we have available to meet our cash commitments and make additional investments&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to recover the significant upfront costs in our partner relationships and develop our partner relationships over time&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to attract new partners and successfully capture new opportunities&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the increasing number of risk-sharing arrangements we enter into with our partners could limit or negatively impact our profitability&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to estimate the size of our target markets for our services&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to maintain and enhance our reputation and brand recognition&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">consolidation in the health care industry&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">competition which could limit our ability to maintain or expand market share within our industry&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks related to audits by Centers for Medicare and Medicaid Services and other governmental payers and actions, including whistleblower claims under the False Claims Act&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to partner with providers due to exclusivity provisions in our contracts in some of our partner and founder contracts&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks related to managing our offshore operations and cost reduction goals&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to contain health care costs, implement increases in premium rates on a timely basis, maintain adequate reserves for policy benefits or maintain cost effective provider agreements&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our dependency on our key personnel, and our ability to attract, hire, integrate and retain key personnel&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the impact of additional goodwill and intangible asset impairments on our results of operations&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our indebtedness, our ability to service our indebtedness, and our ability to obtain additional financing on favorable terms or at all&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to achieve profitability in the future&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the impact of litigation proceedings, government inquiries, reviews, audits or investigations&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">material weaknesses in the future may impact our ability to conclude that our internal control over financial reporting is not effective and we may be unable to produce timely and accurate financial statements&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions on the manner in which we access personal data and penalties as a result of privacy and data protection laws&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">liabilities and reputational risks related to our ability to safeguard the security and privacy of confidential data</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">data loss or corruption due to failures or errors in our systems and service disruptions at our data centers&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">adequate protection of our intellectual property, including trademarks&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risks related to legal proceedings related to any alleged infringement, misappropriation or violation of third-party intellectual property rights&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our use of &#8220;open source&#8221; software&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to protect the confidentiality of our trade secrets, know-how and other proprietary information&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our reliance on third parties and licensed technologies&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions on our ability to use, disclose, de-identify or license data and to integrate third-party technologies&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our reliance on Internet infrastructure, bandwidth providers, data center providers, other third parties and our own systems for providing services to our partners&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our reliance on third-party vendors to host and maintain our technology platform&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our obligations to make material payments to certain of our pre-IPO investors for certain tax benefits we may claim in the future&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to utilize benefits under the tax receivables agreement we entered into with certain of our pre-IPO investors&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our obligations to make payments under the tax receivables agreement that may be accelerated or may exceed the tax benefits we realize&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the terms of agreements between us and certain of our pre-IPO investors may contain different terms than comparable agreements we may enter into with unaffiliated third parties&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the conditional conversion features of the 1.50% Convertible Senior Notes due 2025 (the &#34;2025 Notes&#34;), which, if triggered, could require us to settle the 2025 Notes in cash&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interest rate risk under the Credit Agreement, and the terms of our Cumulative Series A Convertible Preferred Shares, par value $0.01 per share (&#8220;Series A Preferred Stock&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our debt following the NIA acquisition and our ability to meet our obligations&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to service our debt and pay dividends on our Series A Preferred Stock&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the potential volatility of our Class A common stock price&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the potential decline of our Class A common stock price if a substantial number of shares are sold or become available for sale, including those issuable upon conversion of our Series A Preferred Stock&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our Series A Preferred Stock has rights, preferences and privileges that are not held by and are preferential to the rights of holders of our Class A common stock, and could in the future substantially dilute the ownership interest of holders of our Class A common stock</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">provisions in our certificate of incorporation and by-laws and provisions of Delaware law that discourage or prevent strategic transactions, including a takeover of us&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ability of certain of our investors to compete with us without restrictions&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">provisions in our certificate of incorporation, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our intention not to pay cash dividends on our Class A common stock.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks included here are not exhaustive. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the &#8220;2022 Form 10-K&#8221;), and to the extent applicable, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, and other documents filed with the SEC include additional factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this prospectus supplement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-4</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_170"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and, accordingly, file annual, quarterly and periodic reports, proxy statements and other information with the SEC. Our SEC filings, including our registration statement, are available to you, free of charge, on the SEC&#8217;s website at www.sec.gov. Our SEC filings will also be available on our website at ir.evolenthealth.com. The information contained on or linked to or from our website is not incorporated by reference into this prospectus supplement, the accompanying prospectus or the registration statement of which they form a part. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC an automatic shelf registration statement on Form S-3, including exhibits filed with the registration statement of which this prospectus supplement is a part, under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the shares of our Class A common stock offered hereby. This prospectus supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement and exhibits to the registration statement. For further information with respect to our Company and shares of our Class A common stock offered hereby, reference is made to the registration statement, including the exhibits to the registration statement. Statements contained in this prospectus supplement and the accompanying prospectus as to the contents of any contract or other document referred to in this prospectus supplement and the accompanying prospectus are not necessarily complete and, where that contract is an exhibit to the registration statement, each statement is qualified in all respects by the exhibit to which the reference relates. Copies of the registration statement, including the exhibits to the registration statement, may be reviewed through the SEC&#8217;s website, as described above. </font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_187"></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCORPORATION BY REFERENCE</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement is part of an automatic shelf registration statement on Form S-3 filed with the SEC. This prospectus supplement does not contain all of the information included in the registration statement, certain parts of which are omitted in accordance with the rules and regulations of the SEC. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to &#8220;incorporate by reference&#8221; certain information into this prospectus supplement from certain documents that we filed with the SEC prior to the date of this prospectus supplement. By incorporating by reference, we are disclosing important information to you by referring you to documents we have filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus supplement and the accompanying prospectus, except for information incorporated by reference that is modified or superseded by information contained in this prospectus supplement or the accompanying prospectus or in any other subsequently filed document that also is incorporated by reference herein. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to be part of this prospectus supplement and the accompanying prospectus. These documents contain important information about us, our business and our financial performance. The following documents are incorporated by reference into this prospectus supplement, except for any document or portion thereof deemed to be furnished and not filed in accordance with SEC rules&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000029/evh-20221231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December 31, 2022, filed with the SEC on February 24, 2023&#59;</font></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Quarterly Reports on Form 10-Q for the quarters ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000066/evh-20230331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000121/evh-20230630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 30, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001628908/000162890823000165/evh-20230930.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">September 30, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on May 4, 2023, August 3, 2023, and November 2, 2023, respectively&#59;</font></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">The portions of our </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000119312523126887/d378548ddef14a.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitive Proxy Statement</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Schedule 14A filed with the SEC on April 28, 2023 that are incorporated by reference into Part III of our 2022 Form 10-K&#59;</font></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">The description of our Class A common stock included in our registration statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1628908/000119312515214021/d936600d8a12b.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8-A</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on June 5, 2015, as updated by </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1628908/000162890822000027/evh10-kexhibit46.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 4.6</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our 2022 Form 10-K, and any amendment or report filed with the SEC for the purpose of updating such description&#59; and </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Current Reports on Form 8-K filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000119312523012645/d331612d8k.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">January 23, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (as amended by Amendment No. 1 on Form 8-K&#47;A filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000141/evh-20230119.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">September 26, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Amendment No. 2 on Form 8-K&#47;A filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000149/evh-20230119.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">October 16, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000010/evh-20230214.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 15, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000051/evh-20230328.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 29, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000056/evh-20230419.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">April 19, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000061/evh-20230503.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May 3, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000076/evh-20230608.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 8, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000115/evh-20230726.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">July 26, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000119/evh-20230802.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 2, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (as amended by Amendment No. 1 on Form 8-K&#47;A filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000130/evh-20230802.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 4, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">November </a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">, 2023</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> (Film No.</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">231374135</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">)</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than any portions thereof deemed furnished and not filed).</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also specifically incorporate by reference any documents filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date we file this prospectus supplement and prior to the termination of the offering of securities covered by this prospectus supplement, except for any document or portion thereof deemed to be &#8220;furnished&#8221; and not filed in accordance with SEC rules. The information relating to us contained in this prospectus supplement does not purport to be comprehensive and should be read together with the information contained in the documents incorporated or deemed to be incorporated by reference herein. </font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you request, either orally or in writing, we will provide you with a copy of any or all documents that are incorporated by reference herein. Such documents will be provided to you free of charge, but will not contain any exhibits, unless those exhibits are incorporated by reference into the document. Requests can be made by writing to Investor Relations at 800 N. Glebe Road, Suite 500, Arlington, Virginia 22203 or by phone at (571) 389-6000. The documents may also be accessed on our website at ir.evolenthealth.com. Information contained on our website is not incorporated by reference into this prospectus supplement, the accompanying prospectus or the registration statement of which they form a part. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-6</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUMMARY</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary is not complete and does not contain all of the information that you should consider before investing in our Class A common stock. You should read carefully this entire prospectus supplement and the accompanying prospectus, including the information incorporated by reference from our 2022 Form 10-K and the other incorporated documents, including in particular the section entitled &#8220;Risk Factors&#8221; of this prospectus supplement and in such incorporated documents, as well as our consolidated financial statements, incorporated by reference in this prospectus supplement and the accompanying prospectus, before making any investment decision.</font></div><div style="margin-bottom:9pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a market leader in the new era of value-based care, in which the delivery of health care is increasingly funded by at-risk payment models. We provide integrated solutions to both health care providers, including independent physicians and health systems, as well as payers, including health plans and other risk-bearing organizations, with a common end&#58; to improve health care quality and outcomes while reducing cost. We consider value-based care to be the necessary convergence of health care payment and delivery. We believe the pace of this convergence is accelerating, driven by price pressure in traditional FFS health care, a market environment that is incentivizing value-based care models, growth in consumer-focused insurance programs, such as Medicare Advantage and managed Medicaid, and innovation in data and technology.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a broad spectrum of specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care improvement along with an integrated platform for health plan administration and value-based business infrastructure under one reportable segment. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Corporate Information </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolent was founded in 2011 by members of our management team, University of Pittsburgh Medical Center, an integrated delivery system in Pittsburgh, Pennsylvania, and The Advisory Board Company, to enable providers to pursue a value-based business model and evolve their competitive position and market opportunity. Since that time, we have grown both organically and through acquisitions. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 800 N. Glebe Road, Suite 500, Arlington, Virginia 22203. Our telephone number is (571) 389-6000. Our website address is www.evolenthealth.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus supplement or in deciding whether to purchase our Class A common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-7</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RISK FACTORS</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in our Class A common stock involves a high degree of risk. You should carefully consider all of the information contained in, or incorporated by reference into, this prospectus supplement and the accompanying prospectus, including the risk factors incorporated by reference in this prospectus supplement from our 2022 Form 10-K under the heading &#8220;Risk Factors&#8221; and the audited annual financial statements and notes thereto, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023, as updated by our subsequent filings under the Exchange Act, before purchasing shares of our Class A common stock. See &#8220;Where You Can Find More Information&#8221; for information about how to obtain a copy of these documents. If any of those risks are realized, our business, financial condition, operating results and prospects could be materially and adversely affected. In that event, the price of our Class A common stock could decline, and you could lose part or all of your investment. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-8</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_205"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USE OF PROCEEDS</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the shares of our Class A common stock offered by this prospectus supplement will be sold by the selling stockholders. We will not receive any cash proceeds from any resale of our Class A common stock by the selling stockholders. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-9</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_225"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SELLING STOCKHOLDERS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2023 (the &#8220;Closing Date&#8221;), the Company acquired NIA and certain assets held by Magellan Health, Inc., and&#47;or certain of its subsidiaries used in the Magellan Specialty Health Division (the &#8220;NIA Acquisition&#8221;) pursuant to a Stock and Asset Purchase Agreement among the Company, EVH LLC, Magellan Health, Inc. (&#8220;Magellan Parent&#8221;), and Magellan Healthcare, Inc., a Delaware corporation (&#8220;Magellan&#8221;), for cash consideration of approximately $387.8 million (inclusive of certain post-closing adjustments) and share consideration of 8,474,576 shares of the Company&#8217;s Class A common stock (the &#8220;Share Consideration&#8221; or &#8220;Registered Shares&#8221;) issued to Magellan Parent. In connection with the NIA Acquisition, on the Closing Date, the Company entered into a Registration Rights Agreement with Magellan Parent (the &#8220;Registration Rights Agreement&#8221;), which granted certain registration rights to Magellan Parent in respect of the Share Consideration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2023, Magellan Parent sold the shares comprising the Share Consideration to the selling stockholders, and the selling stockholders became parties to the Registration Rights Agreement. The selling stockholders may from time to time, in one or more offerings, offer and sell any or all of the shares of our Class A common stock set forth below pursuant to this prospectus supplement, which we are registering for resale by them in accordance with the terms of the Registration Rights Agreement.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth, as of the date of this prospectus supplement, the name of each selling stockholder for whom we are registering shares of Class A common stock for resale to the public, and the number of shares of our Class A common stock that each selling stockholder may offer pursuant to this prospectus supplement. We have prepared this information and the following table based on information given to us by, or on behalf of, the selling stockholders on or before the date of this prospectus supplement. We have not independently verified this information. Information about the selling stockholders may change over time. As used in this prospectus supplement, unless otherwise noted or the context otherwise requires, the term &#8220;selling stockholders&#8221; includes the selling stockholders listed below and their respective permitted transferees, pledgees, assignees, transferees, donees and successors-in-interest and any other person named as a selling stockholder in any applicable prospectus supplement. We may amend or supplement this prospectus supplement from time to time in the future to update or change information about the selling stockholders to identify any permitted transferees, pledgees, assignees, transferees, donees and successors-in-interest of our Class A common stock. The registration of the Class A common stock does not necessarily mean that the selling stockholders will sell all or any of the Class A common stock they own pursuant to this prospectus supplement. In addition, the selling stockholders may sell, transfer or otherwise dispose of, at any time and from time to time, Class A common stock in transactions exempt from the registration requirements of the Securities Act after the date on which the selling stockholders provided the information set forth on the table below.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, the selling stockholders listed below have sole voting and investment power with respect to the indicated shares of our Class A common stock. Information in the table below with respect to beneficial ownership has been furnished by the selling stockholders.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock Beneficially Owned</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior to this Offering</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock Beneficially Owned</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After this Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beneficial Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Shares</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beneficially</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Being</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beneficially</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Destiny Portfolios&#58; Fidelity Advisor Diversified Stock Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Founders Investment Trust</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,800</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,800</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Concord Street Trust&#58; Fidelity Founders Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Puritan Trust&#58; Fidelity Puritan Fund - Equity Sub B</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976,600</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976,600</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Concord Street Trust&#58; Fidelity Mid-Cap Stock Fund</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Mid-Cap Stock Commingled Pool</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Concord Street Trust&#58; Fidelity Mid-Cap Stock K6 Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Mt. Vernon Street Trust&#58; Fidelity New Millennium Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Advisor Series VII&#58; Fidelity Advisor Health Care Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,226</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,774</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Advisers Core Fund - FIAM Sector Managed Health Care Sub &#47; Strategic Advisers Large Cap Fund &#8211; FIAM Sector Managed Health Care Sub - 56003</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Select Portfolios&#58; Health Care Portfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178,600</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Select Portfolios&#58; Medical Technology and Devices Portfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244,900</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241,400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Central Investment Portfolios LLC&#58; Fidelity U.S. Equity Central Fund - Health Care Sub</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Insurance Products Fund IV&#58; VIP Health Care Portfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Insurance Products Fund III&#58; VIP Mid Cap Portfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Advisor Series I&#58; Fidelity Advisor Mid Cap II Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Insurance Products Fund&#58; VIP Stock Selector All Cap Portfolio Health Care Subportfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strategic Advisers Fidelity U.S. Total Stock Fund - FIAM Sector Managed - Health Care Sub</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Capital Trust&#58; Fidelity Capital Appreciation Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,900</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,900</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Products Fund III&#58; VIP Dynamic Capital Appreciation Portfolio</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Select Portfolios&#58; Select Health Care Services Portfolio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Hastings Street Trust&#58; Fidelity Growth Discovery Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Advisor Series I&#58; Fidelity Advisor Series Equity Growth Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fidelity Advisor Series I&#58; Fidelity Advisor Equity Growth Fund</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Insurance Products Fund&#58; VIP Growth Portfolio</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,300</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,300</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Represents less than 1%.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:29.2pt">These funds and accounts are managed by direct or indirect subsidiaries of FMR LLC. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC.  Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#8217; voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#8217; voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC.  The address of these funds and accounts is 245 Summer Street, Boston, MA 02210.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:29.2pt">Assumes that each selling stockholder will resell all of the shares of our Class A common stock offered hereunder.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:29.2pt">Based on 114,959,689 shares of our Class A common stock outstanding as of October 30, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-12</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_246"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders, including their pledgees, donees, transferees, distributees, beneficiaries or other successors-in-interest, may from time to time offer some or all of the Registered Shares.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders will not pay any of the costs, expenses and fees in connection with the registration and sale of the Registered Shares covered by this prospectus supplement, but it will pay any and all underwriting discounts, selling commissions and stock transfer taxes, if any, attributable to sales of the Registered Shares. We will not receive any proceeds from the sale of our shares of Class A common stock covered hereby.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may sell the Registered Shares covered by this prospectus supplement from time to time, and may also decide not to sell all or any of the Registered Shares that it is allowed to sell under this prospectus supplement. The selling stockholders will act independently of us in making decisions regarding the timing, manner and size of each sale. These dispositions may be at fixed prices, at market prices prevailing at the time of sale, at prices related to such prevailing market prices, at varying prices determined at the time of sale, or at privately negotiated prices. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may use any one or more of the following methods when selling shares&#58;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through underwriters, brokers or dealers or agents for resale to the public or to institutional investors at various times&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in one or more underwritten offerings on a firm commitment or best efforts basis&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through negotiated transactions, including, but not limited to, block trades in which the broker or dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through brokers or dealers, who may act as agents or principals&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">on any national securities exchange or quotation service on which the shares may be listed or quoted at the time of sale at market prices prevailing at the time of sale, at prices related to such prevailing market prices, or at negotiated prices&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">sales in the over-the-counter market&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in private transactions other than exchange or quotation service transactions&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through short sales, purchases or sales of put, call or other types of options, forward delivery contracts, swaps, offerings of structured equity-linked securities or other derivative transactions or securities&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through the writing or settlement of options or other hedging transactions, whether or not the options are listed on an options exchange&#894; </font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through offerings of securities exercisable, convertible or exchangeable for shares, including, without limitation, securities issued by trusts, investment companies or other entities&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through offerings directly to one or more purchasers, including institutional investors&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through distributions or transfers to their respective members, partners or shareholders&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through ordinary brokerage transactions and transactions in which a broker solicits purchasers&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in &#8220;at the market&#8221; offerings as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents&#894;</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through a combination of any such methods of sale&#894; or</font></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">through any other method permitted under applicable law. </font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may also resell all or a portion of its Registered Shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided it meets the criteria and conforms to the requirements of Rule 144 and all applicable laws and regulations.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the Registered Shares and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Registered Shares, from time to time, under this prospectus or under an amendment or supplement to this prospectus amending the list of selling stockholders to include the pledgees, transferees or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the Registered Shares in other circumstances, in which case the pledgees, assignees, permitted transferees, donees or other successors-in-interest will be the selling beneficial owners for purposes of this prospectus.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may enter into sale, forward sale and derivative transactions with third parties, or may sell securities not covered by this prospectus supplement to third parties in privately negotiated transactions. In connection with those sale, forward sale or derivative transactions, the third parties may sell securities covered by this prospectus supplement, including in short sale transactions and by issuing securities that are not covered by this prospectus supplement but are exchangeable for or represent beneficial interests in the common stock. The third parties also may use shares received under those sale, forward sale or derivative arrangements or shares pledged by the selling stockholders or borrowed from the selling stockholders or others to settle such third-party sales or to close out any related open borrowings of common stock. The third parties may deliver this prospectus supplement in connection with any such transactions. Any third party in such sale transactions will be an underwriter and will be identified in a supplement or a post-effective amendment to the registration statement of which this prospectus supplement is a part as may be required.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the selling stockholders may engage in hedging transactions with broker-dealers in connection with distributions of Registered Shares or otherwise. In those transactions, broker-dealers may engage in short sales of securities in the course of hedging the positions they assume with the selling stockholders. The selling stockholders may also sell securities short and redeliver securities to close out such short positions. The selling stockholders may also enter into option or other transactions with broker-dealers which require the delivery of securities to the broker- dealer. The broker-dealer may then resell or otherwise transfer such securities pursuant to this prospectus supplement. The selling stockholders also may loan or pledge shares, and the borrower or pledgee may sell or otherwise transfer the Registered Shares so loaned or pledged pursuant to this prospectus supplement. Such borrower or pledgee also may transfer those Registered Shares to investors in our securities or the selling stockholders&#8217; securities or in connection with the offering of other securities not covered by this prospectus supplement.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent necessary, the specific terms of the offering of Registered Shares, including the specific Registered Shares to be sold, the respective purchase prices and public offering prices, the names of any underwriter, broker-dealer or agent, if any, and any applicable compensation in the form of discounts, concessions or commissions paid to underwriters or agents or paid or allowed to dealers will be set forth in a supplement to this prospectus supplement or a post-effective amendment to this registration statement of which this prospectus supplement forms a part. The selling stockholders may, or may authorize underwriters, dealers and agents to, solicit offers from specified institutions to purchase Registered Shares from the selling stockholders at the public offering price listed in the applicable prospectus supplement. These sales may be made under &#8220;delayed delivery contracts&#8221; or other purchase contracts that provide for payment and delivery on a specified future date. Any contracts like this will be described in and be subject to the conditions set forth in a supplement to this prospectus supplement or a post-effective amendment to this registration statement of which this prospectus supplement forms a part.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broker-dealers or agents may receive compensation in the form of commissions, discounts or concessions from the selling stockholders. Broker-dealers or agents may also receive compensation from the purchasers of Registered Shares for whom they act as agents or to whom they sell as principals, or both. Compensation as to a particular broker-dealer might be in excess of customary commissions and will be in amounts to be negotiated in connection with transactions involving securities. In effecting sales, broker-dealers engaged by the selling stockholders may arrange for other broker-dealers to participate in the resales.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with sales of Registered Shares covered hereby, the selling stockholders and any underwriter, broker-dealer or agent, any other participating broker-dealer that executes sales for the selling stockholders may be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act. Accordingly, any profits realized by the selling stockholders and any compensation earned by such underwriter, broker-dealer or agent may be deemed to be underwriting discounts and commissions. If  any selling stockholder is an &#8220;underwriter&#8221; under the Securities Act, it must deliver this prospectus supplement and the accompanying prospectus in the manner required by the Securities Act. This delivery requirement may be satisfied through the facilities of the New York Stock Exchange in accordance with Rule 153 under the Securities Act or satisfied in accordance with Rule 174 under the Securities Act.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or the selling stockholders may agree to indemnify any underwriters, broker-dealers and agents against or contribute to any payments the underwriters, broker-dealers or agents may be required to make with respect to, civil liabilities, including liabilities under the Securities Act. Underwriters, broker-dealers and agents and their affiliates are permitted to be customers of, engage in transactions with, or perform services for us and our affiliates or the selling stockholders or its affiliates in the ordinary course of business.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to comply with applicable securities laws of some states or countries, the Registered Shares may only be sold in those jurisdictions through registered or licensed brokers or dealers and in compliance with applicable laws and regulations. In addition, in certain states or countries the Registered Shares may not be sold unless they have been registered or qualified for sale in the applicable state or country or an exemption from the registration or qualification requirements is available. Any Registered Shares covered by this prospectus supplement that qualify for sale pursuant to Rule 144 under the Securities Act may be sold in open market transactions under Rule 144 rather than pursuant to this prospectus supplement.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with an offering of Registered Shares under this prospectus supplement, the underwriters may purchase and sell securities in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of securities than they are required to purchase in an offering. Stabilizing transactions consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the market price of the securities while an offering is in progress.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the underwriters have repurchased securities sold by or for the account of that underwriter in stabilizing or short-covering transactions.</font></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These activities by the underwriters may stabilize, maintain or otherwise affect the market price of the Registered Shares offered under this prospectus supplement. As a result, the price of the Registered Shares may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by the underwriters at any time. These transactions may be effected on the New York Stock Exchange, the NASDAQ Stock Exchange or another securities exchange or automated quotation system, or in the over-the-counter market or otherwise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-15</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_265"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LEGAL MATTERS </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The validity of the Class A common stock offered hereby has been passed upon for us by King &#38; Spalding LLP. </font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_309"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXPERTS </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of Evolent Health, Inc. as of December 31, 2022 and 2021, and for each of the three years in the period ended December 31, 2022, incorporated by reference herein by reference to Evolent Health, Inc.&#8217;s annual report on Form 10-K for the year ended December 31, 2022, and the effectiveness of Evolent Health, Inc.&#8217;s internal control over financial reporting have been audited by Deloitte &#38; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combined financial statements of Magellan Specialty Health as of December 31, 2022, and for the year then ended, have been incorporated by reference herein in reliance upon the report of Marcum LLP, independent registered public accounting firm, upon the authority of said firm as an expert in accounting and auditing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-16</font></div><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_344"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_348"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROSPECTUS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.721%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" rowspan="3" style="padding:0 1pt"><div style="margin-bottom:0.08pt;text-align:center"><img alt="image0a06a.jpg" src="image0a06a.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:280px"></div></td></tr><tr style="height:29pt"><td colspan="3" style="display:none"></td></tr><tr style="height:29pt"><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">Evolent Health, Inc. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">CLASS A COMMON STOCK</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:0.09pt"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus covers the resale by selling stockholders of shares of our Class A common stock, par value $0.01 per share (&#8220;Class A common stock&#8221;).</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders, who will be named in a prospectus supplement, may offer and sell shares of our Class A common stock, from time to time in amounts, at prices, and on terms that will be determined at the time of any such offering. We will not receive any proceeds from the sale of our Class A common stock by the selling stockholders. This prospectus describes some of the general terms that may apply to our Class A common stock.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each time any of the selling stockholders offer and sell shares of our Class A common stock, such selling stockholders will provide a supplement to this prospectus that contains specific information about the offering and the selling stockholders, as well as the amounts and prices of the Class A common stock to be offered and sold. The applicable prospectus supplement may also add, update or change information contained in this prospectus with respect to that offering. You should read this prospectus and the accompanying prospectus supplement, as well as the documents incorporated by reference herein or therein, carefully before you make your investment decision. This prospectus may not be used to offer and sell shares of our Class A common stock unless accompanied by a prospectus supplement or a free writing prospectus.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may offer and sell the Class A common stock described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of our Class A common stock, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#8220;About this Prospectus&#8221; and &#8220;Plan of Distribution&#8221; for more information.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Class A common stock is listed on The New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;EVH.&#8221; The last reported closing sale price of our Class A common stock on August 2, 2022 was $35.21 per share.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in shares of our Class A common stock involves risk. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i1f6bdbdece6446dca24b928102f9dfe8_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; beginning on page 2.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the shares of our Class A common stock or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></div><div style="margin-bottom:0.09pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.09pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:0.09pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The date of this prospectus is August 3, 2022</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_352"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of contents</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.971%"><tr><td style="width:1.0%"></td><td style="width:89.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">About this Prospectus</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Risk Factors</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Cautionary Statement Regarding Forward-Looking Statements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Where You Can Find More Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Incorporation by Reference</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">About Us</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">4</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Use of Proceeds</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Selling Stockholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Description of Class A Common Stock</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">7</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Plan of Distribution</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Legal Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Experts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">15</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_358"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ABOUT THIS PROSPECTUS </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus is part of a registration statement that we filed as a &#8220;well-known seasoned issuer,&#8221; or &#8220;WKSI,&#8221; as defined in Rule 405 of the Securities Act, with the Securities and Exchange Commission (the &#8220;SEC&#8221;) using the &#8220;automatic shelf&#8221; registration process. Under the automatic shelf registration process, the selling stockholders may, from time to time, offer and&#47;or sell our Class A common stock in one or more offerings or resales. This prospectus provides you with a general description of the Class A common stock that the selling stockholders may offer. Each time the selling stockholders offer and sell shares of our Class A common stock using this prospectus, we will provide a prospectus supplement and attach it to this prospectus and may also provide you with a free writing prospectus. The prospectus supplement and any free writing prospectus will contain more specific information about the shares of Class A common stock being offered and sold and the specific terms of that offering. The prospectus supplement may also add, update, change, or clarify information contained in or incorporated by reference into this prospectus. Any statement that we make in this prospectus will be modified or superseded by any inconsistent statement made by us or the selling stockholders in a prospectus supplement. If the information in this prospectus is inconsistent with the information in any applicable prospectus supplement, any applicable amendment or any applicable free writing prospectus, you should rely on the information in that prospectus supplement, amendment or free writing prospectus&#59; provided, that if any statement in one of these documents is inconsistent with a statement in another document having a later date&#8212;for example, a document incorporated by reference into this prospectus or any prospectus supplement or any applicable free writing prospectus&#8212;the statement in the document having the later date modifies or supersedes the earlier statement. Before making an investment in our Class A common stock, you should read both this prospectus and, if applicable, any prospectus supplement or any free writing prospectus, as well as the other information contained or incorporated by reference in this prospectus or in any prospectus supplement hereto. See &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation by Reference&#8221; for more information. This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of the documents referred to herein have been filed, or will be filed or incorporated by reference, as exhibits to the registration statement of which this prospectus is a part. The registration statement, including the exhibits and documents incorporated or deemed incorporated by reference in this prospectus, can be read on the SEC website mentioned under the heading &#8220;Where You Can Find More Information.&#8221; </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither we nor any selling stockholders have authorized anyone to provide you with information other than that contained in this prospectus or in any accompanying prospectus supplement or free writing prospectus prepared by or on behalf of us or to which we have referred you. We and any selling stockholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus or any accompanying prospectus supplement does not constitute an offer to sell or a solicitation of an offer to buy any shares of our Class A common stock other than the registered shares to which they relate, and this prospectus or any accompanying prospectus supplement does not constitute an offer to sell or the solicitation of an offer to buy shares in any jurisdiction where, or to any person to whom, it is unlawful to make such an offer or solicitation. You should not assume that the information contained in this prospectus and any accompanying prospectus supplement is correct on any date after the respective dates of the prospectus and such prospectus supplement or supplements, as applicable, even though this prospectus and such prospectus supplement or supplements are delivered or shares are sold pursuant to the prospectus and such prospectus supplement or supplements at a later date. Since the respective dates of the prospectus contained in this registration statement and any accompanying prospectus supplement, our business, financial condition, results of operations and prospects may have changed. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated or required by the context, references in this prospectus to &#8220;Evolent,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;our company&#8221; and &#8220;the company&#8221; refer to Evolent Health, Inc., a Delaware corporation, together with its consolidated subsidiaries. </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_364"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RISK FACTORS </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in our Class A common stock involves risks. You should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on Form 10-Q, together with the other information contained in this prospectus, or any prospectus supplement or incorporated by reference herein or therein, before purchasing shares of our Class A common stock. See &#8220;Where You Can Find More Information&#8221; for information about how to obtain a copy of these documents. If any of those risks are realized, our business, financial condition, operating results and prospects could be materially and adversely affected. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In that event, the price of our Class A common stock could decline, and you could lose part or all of your investment. </font></div><div style="margin-top:12pt"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_368"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements made in this prospectus and the documents incorporated herein by reference and in other written or oral statements made by us or on our behalf are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like&#58; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;aim,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;shall,&#8221; &#8220;may,&#8221; &#8220;might&#8221; and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this prospectus, and any accompanying prospectus supplement, primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and results of operations. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this prospectus and any accompanying prospectus supplement. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this prospectus and any accompanying prospectus supplement. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. Please refer to the &#8220;Risk Factors&#8221; section in this prospectus, any accompanying prospectus supplement, and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, and, to the extent applicable, our Quarterly Reports on Form 10-Q. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The forward-looking statements made in this prospectus and any accompanying prospectus supplement relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this prospectus and any accompanying prospectus supplement to reflect events or circumstances after the date of this prospectus and any accompanying prospectus supplement or to reflect new information or the occurrence of unanticipated events, except as required by law. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of factors that could materially affect the outcome of our forward-looking statements, see &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K, which are incorporated by reference in this prospectus, and, to the extent applicable, our Quarterly Reports on Form 10-Q and any accompanying prospectus supplement. </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_372"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">WHERE YOU CAN FIND MORE INFORMATION </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and, accordingly, file annual, quarterly and periodic reports, proxy statements and other information with the SEC. Our SEC filings, including our registration statement, are available to you, free of charge, on the SEC&#8217;s website at www.sec.gov. Our SEC filings will also be available on our website at ir.evolenthealth.com. The information contained on or linked to or from our website is not incorporated by reference into this prospectus or the registration statement of which they form a part. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC an automatic shelf registration statement on Form S-3, including exhibits filed with the registration statement of which this prospectus supplement is a part, under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the shares of our Class A common stock registered hereby. This prospectus and any applicable prospectus supplements do not contain all of the information set forth in the registration statement and exhibits to the registration statement. For further information with respect to our Company and the shares of our Class A common stock registered hereby, reference is made to the registration statement, including the exhibits to the registration statement. Statements contained in this prospectus and any applicable prospectus supplement as to the contents of any contract or other document referred to in this prospectus and any applicable prospectus supplement are not necessarily complete and, where that contract is an exhibit to the registration statement, each statement is qualified in all respects by the exhibit to which the reference relates. Copies of the registration statement, including the exhibits to the registration statement, may be reviewed through the SEC&#8217;s website, as described above. </font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_376"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">INCORPORATION BY REFERENCE </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to &#8220;incorporate by reference&#8221; certain information into this prospectus from certain documents that we filed with the SEC prior to the date of this prospectus and that we will file in the future. By incorporating by reference, we are disclosing important information to you by referring you to documents we have filed, or will file, separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, except for information incorporated by reference that is modified or superseded by information contained in this prospectus or in any other subsequently filed document that also is incorporated by reference herein. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to be part of this prospectus. These documents contain or will contain important information about us, our business and our financial performance. The following documents are incorporated by reference into this prospectus, except for any document or portion thereof deemed to be furnished and not filed in accordance with SEC rules&#58; </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000027/evh-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December 31, 2021, filed with the SEC on February 24, 2022 (our &#8220;2021 10-K&#8221;)&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Quarterly Reports on Form 10-Q for the quarters ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000063/evh-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000098/evh-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 30, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000063/evh-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May 5, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000098/evh-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 3, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">The portions of our </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1628908/000119312522133588/d326880ddef14a.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitive Proxy Statement</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Schedule 14A filed with the SEC on April 29, 2022 that are incorporated by reference into Part III of our 2021 10-K&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">The description of our Class A common stock included in our registration statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1628908/000119312515214021/d936600d8a12b.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8-A</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on June 5, 2015, as updated by </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1628908/000162890822000027/evh10-kexhibit46.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 4.6</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our 2021 10-K, and any amendment or report filed with the SEC for the purpose of updating such description&#59; and </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.35pt">Our Current Reports on Form 8-K filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000012/evh-20220210.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 11, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000050/evh-20220301.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 7, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000067/evh-20220609.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 9, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000088/evh-20220624.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 29, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1628908/000162890822000093/evh-20220801.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 2, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than any portions thereof deemed furnished and not filed). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all documents that we subsequently file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date of this prospectus and prior to the termination of each offering under this</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prospectus, shall be deemed to be incorporated by reference into this prospectus. We are not, however, incorporating, in each case, any documents (or portions thereof) or information that we are deemed to furnish and not file in accordance with SEC rules unless expressly stated otherwise. Any statement in this prospectus, in any prospectus supplement, or in any document incorporated by reference that is different from any statement contained in any later-filed document should be regarded as changed by that later statement. Once so changed, the earlier statement is no longer considered part of this prospectus or any prospectus supplement. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information relating to us contained in this prospectus does not purport to be comprehensive and should be read together with the information contained in the documents incorporated or deemed to be incorporated by reference into this prospectus. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you request, either orally or in writing, we will provide you with a copy of any or all documents that are incorporated by reference herein. Such documents will be provided to you free of charge, but will not contain any exhibits, unless those exhibits are incorporated by reference into the document. Requests can be made by writing to Investor Relations at 800 N. Glebe Road, Suite 500, Arlington, Virginia 22203 or by phone at (571) 389-6000. The documents may also be accessed on our website at ir.evolenthealth.com. Information contained on our website is not incorporated by reference into this prospectus and you should not consider information contained on our website to be part of this prospectus or any prospectus supplement. </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_380"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ABOUT US </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolent Health, Inc. is a holding company whose principal asset is all of the Class A common units it holds in Evolent Health LLC, and its only business is to act as sole managing member of Evolent Health LLC. Substantially all of our operations are conducted through Evolent Health LLC and its consolidated subsidiaries. The financial results of Evolent Health LLC are consolidated in the financial statements of Evolent Health, Inc. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a market leader in the new era of value-based care, in which the delivery of health care is increasingly funded by at-risk payment models. We provide integrated solutions to both health care providers, including independent physicians and health systems, as well as payers, including health plans and other risk-bearing organizations, with a common end&#58; to improve health care quality and outcomes while reducing cost. We consider value-based care to be the necessary convergence of health care payment and delivery. We believe the pace of this convergence is accelerating, driven by price pressure in traditional FFS health care, a market environment that is incentivizing value-based care models, growth in consumer-focused insurance programs, such as Medicare Advantage and managed Medicaid, and innovation in data and technology. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our operations and allocate resources across two reportable segments&#58; Evolent Health Services (&#8220;EHS&#8221;) and Clinical Solutions. The Company&#8217;s EHS segment provides an integrated administrative and clinical platform for health plan administration and population health management. Our Clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for Specialty Care Management in Oncology and Cardiology and holistic Total Cost of Care improvement. Our economic opportunity in the Clinical Solutions segment, which we believe to be significant, is largely based on (a) the total amount of medical expenses under management, and (b) the amount of savings we are able to generate relative to a benchmark or target. These partnerships, which we refer to as performance-based arrangements, include both capitation and shared savings arrangements. We also generate Clinical Solutions revenue by providing our technology and services platform on a fee basis. We go to market for our Specialty Care Management under the brand name New Century Health, and for our Total Cost of Care solution under the brand name Evolent Care Partners. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Corporate Information </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolent was founded in 2011 by members of our management team, University of Pittsburgh Medical Center (&#8220;UPMC&#8221;), an integrated delivery system in Pittsburgh, Pennsylvania, and The Advisory Board Company, to</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enable providers to pursue a value-based business model and evolve their competitive position and market opportunity. Since that time, we have grown both organically and through acquisitions. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 800 N. Glebe Road, Suite 500, Arlington, Virginia 22203. Our telephone number is (571) 389-6000. Our website address is www.evolenthealth.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our Class A common stock. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_384"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">USE OF PROCEEDS </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not receive any proceeds from the sale of our Class A common stock by the selling stockholders. </font></div><div style="margin-top:12pt"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_388"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SELLING STOCKHOLDERS </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about selling stockholders, including their identities and the number of shares of Class A common stock registered on their behalf, will be set forth in a prospectus supplement, in a post-effective amendment or in documents incorporated by reference into this prospectus that we file with the SEC. No selling stockholder shall sell any shares of our Class A common stock pursuant to this prospectus until we have identified such selling stockholder and the shares being offered for resale by such selling stockholder in a subsequent prospectus supplement or in a post-effective amendment. However, selling stockholders may sell or transfer all or a portion of their shares of our Class A common stock pursuant to any available exemption from the registration requirements of the Securities Act. </font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_392"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF CLASS A COMMON STOCK</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following sets forth certain general terms of the capital stock of Evolent Health, Inc. This information may not be complete in all respects and is qualified in its entirety by reference to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) and our certificate of incorporation and by-laws. Copies of our certificate of incorporation and by-laws have been filed with the SEC and are incorporated by reference as exhibits to the registration statement of which this prospectus is a part. See &#8220;Where You Can Find More Information.&#8221; </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that we may issue up to 750,000,000 shares of Class A common stock, par value $0.01 per share. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting Rights </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided in our certificate of incorporation, or required by law, the holders of Class A common stock are entitled to one vote per share on all matters to be voted upon by the stockholders. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend and Liquidation Rights </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may be applicable to any outstanding preferred stock, the holders of Class A common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by the board of directors out of funds legally available therefor. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently anticipate that we will retain all of our future earnings for use in the expansion and operation of our business and do not anticipate paying any cash dividends in the foreseeable future. The declaration and payment of all future dividends to holders of our Class A common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, earnings, legal requirements and any debt agreements we are then party to, and other factors our board of directors deems relevant. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of liquidation, dissolution or winding up of the Company, the holders of Class A common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Rights </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of our Class A common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Class A common stock. The rights, preferences and privileges of holders of our Class A common stock are subject to those of the holders of any shares of our preferred stock we may issue in the future. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Election and Removal of Directors&#59; Vacancies </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors consists of up to 10 directors, excluding any directors elected by holders of any preferred stock pursuant to provisions applicable in the case of defaults and subject to applicable laws and stock exchange regulations. The exact number of directors will be fixed from time to time by resolution of the board. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our certificate of incorporation and our by-laws, our board of directors currently consists of 10 members. Prior to the 2023 annual meeting of stockholders, our board of directors is divided into three classes of directors, as nearly equal in number as possible. Any director elected prior to the date of the 2021 annual meeting of stockholders will serve for a three-year term expiring on the date of the third annual meeting of stockholders following the annual meeting of stockholders at which that Director was elected. Each director</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elected at the 2021 annual meeting of stockholders was elected for a one-year term expiring at the 2022 annual meeting of stockholders. Each director elected at the 2022 annual meeting of stockholders will be elected for a one-year term expiring at the 2023 annual meeting of stockholders. At the 2023 annual meeting of stockholders and at each annual meeting of stockholders thereafter, all directors will be elected for a one-year term expiring at the next annual meeting of stockholders. There is no limit on the number of terms a director may serve on our board of directors. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our IPO, we entered into a stockholders agreement which contains provisions related to the composition of our board of directors, the committees of our board of directors and our corporate governance. Under the stockholders agreement, for so long as UPMC owns at least 40% of the shares of common stock held by it following the completion of our IPO, such stockholder will be entitled to nominate two directors to serve on our board of directors. When such stockholder owns less than 40% but at least 5% of the shares of common stock held by it following the completion of our IPO, such stockholder will be entitled to nominate one director. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation and our by-laws provide that prior to the date of the 2023 annual meeting of stockholders, any director or the entire Board may be removed only for cause and only upon the affirmative vote of holders of at least 75% of the total voting power of all the then outstanding shares of capital stock entitled to vote generally in the election of directors, voting together as a single class. On or after the date of the 2023 annual meeting of stockholders, any director or the entire Board may be removed, at any time, with or without cause, by the affirmative vote of the holders of at least a majority of the voting power of the outstanding shares of Company&#8217;s capital stock entitled to vote generally in the election of directors, voting together as a single class, subject to the terms of the Stockholders Agreement. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our certificate of incorporation and our by-laws provide that any newly created directorship on the board of directors that results from an increase in the number of directors and any vacancy occurring on the board of directors shall be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Cumulative Voting </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless our certificate of incorporation provides otherwise. Our certificate of incorporation prohibits cumulative voting. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limits on Written Consents </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL permits stockholder action by written consent unless otherwise provided by our certificate of incorporation. Our certificate of incorporation precludes stockholder action by written consent. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder Meetings </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation and our by-laws provide that special meetings of stockholders may be called only by or at the direction of the board of directors, the chairman of the board of directors or the chief executive officer. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment of Certificate of Incorporation </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of holders of at least a majority of the voting power of our outstanding shares of stock will generally be required to amend provisions of our certificate of incorporation. </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment of By-laws </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our by-laws may generally be altered, amended or repealed, and new by-laws may be adopted, by the affirmative vote of either a majority of directors present at any regular or special meeting of the board of directors called for that purpose or by the affirmative vote of the holders of at least a majority of the voting power of the outstanding shares of stock. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Limitations on Stockholder Actions </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our by-laws also impose some procedural requirements on stockholders who wish to&#58; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">make nominations in the election of directors&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">propose that a director be removed&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">propose any repeal or change in our by-laws&#59; or </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">propose any other business to be brought before an annual meeting of stockholders. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these procedural requirements, in order to bring a proposal before a meeting of stockholders, a stockholder must deliver timely notice of a proposal pertaining to a proper subject for presentation at the meeting to our corporate secretary along with the following&#58; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">a description of the business or nomination to be brought before the meeting and the reasons for conducting such business at the meeting&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">the stockholder&#8217;s name and address&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">any material interest of the stockholder in the proposal&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">the number of shares beneficially owned by the stockholder and evidence of such ownership&#59; and </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">the names and addresses of all persons with whom the stockholder is acting in concert and a description of all arrangements and understandings with those persons, and the number of shares such persons beneficially own.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be timely, a stockholder must generally deliver notice&#58; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">in connection with an annual meeting of stockholders, not less than 120 nor more than 150 days prior to the month and day corresponding to the date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event that the date of the annual meeting is more than 30 days before or more than 30 days after the anniversary date of the preceding annual meeting of stockholders, a stockholder notice will be timely if received by us not later than the close of business on the 10th day following the day on which we first publicly announce the date of the annual meeting&#59; or </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">in connection with the election of a director at a special meeting of stockholders, not less than 40 nor more than 60 days prior to the date of the special meeting, but in the event that less than 50 days&#8217; notice or prior public disclosure of the date of the special meeting of the stockholders is given or made to the stockholders, a stockholder notice will be timely if received by us not later than the close of business on the 10th day following the day on which a notice of the date of the special meeting was mailed to the stockholders or the public disclosure of that date was made. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to submit a nomination for our board of directors, a stockholder must also submit any information with respect to the nominee that we would be required to include in a proxy statement, as well as certain other information. If a stockholder fails to follow the required procedures, the stockholder&#8217;s proposal or nominee will be ineligible and will not be voted on by our stockholders. </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Opportunity </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation and the stockholders agreement provide that each of TPG Global, LLC (&#8220;TPG&#8221;), The Advisory Board and UPMC and their respective affiliates will not have any duty to refrain from (i) engaging, directly or indirectly, in the same or similar business activities or lines of business as us, including those business activities or lines of business deemed to be competing with us, or (ii) doing business with any of our clients, customers or vendors. In the event that TPG, The Advisory Board or UPMC or any of their respective affiliates acquires knowledge of a potential business opportunity which may be a corporate opportunity for us, they will have no duty to communicate or offer such corporate opportunity to us. Our certificate of incorporation and the stockholders agreement also provide that, to the fullest extent permitted by law, none of such stockholders or their respective affiliates will be liable to us, for breach of any fiduciary duty or otherwise, by reason of the fact that any such stockholder or any of its affiliates directs such corporate opportunity to another person, or otherwise does not communicate information regarding such corporate opportunity to us, and we will waive and renounce any claim that such business opportunity constituted a corporate opportunity that should have been presented to us. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitation of Liability of Directors and Officers </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that no director will be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except as required by applicable law, as in effect from time to time. Currently, Delaware law requires that liability be imposed for the following&#58; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">any breach of the director&#8217;s duty of loyalty to our company or our stockholders&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">any act or omission not in good faith or which involved intentional misconduct or a knowing violation of law&#59; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL&#59; and </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">any transaction from which the director derived an improper personal benefit.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, neither we nor our stockholders have the right, through stockholders&#8217; derivative suits on our behalf, to recover monetary damages against a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior, except in the situations described above. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our by-laws provide that, to the fullest extent permitted by law, we will indemnify any officer or director of our company against all damages, claims and liabilities arising out of the fact that the person is or was our director or officer, or served any other enterprise at our request as a director, officer, employee, agent or fiduciary. We will reimburse the expenses, including attorneys&#8217; fees, incurred by a person indemnified by this provision when we receive an undertaking to repay such amounts if it is ultimately determined that the person is not entitled to be indemnified by us. Amending these provisions will not reduce our indemnification obligations relating to actions taken before an amendment. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forum Selection </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought on our behalf, any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders and other similar actions, may be brought only in specified courts in the State of Delaware. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers. </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-takeover Effects of Some Provisions </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some provisions of our certificate of incorporation and by-laws could make the following more difficult&#58; </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">acquisitions of control of us by means of a proxy contest or otherwise&#59; or </font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">removal of our incumbent officers and directors. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, as well as our ability to issue preferred stock, are designed to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us, and that the benefits of this increased protection outweigh the disadvantages of discouraging those proposals, because negotiation of those proposals could result in an improvement of their terms. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delaware Business Combination Statute </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected in our certificate of incorporation not to be subject to Section 203 of the DGCL, an antitakeover law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination, such as a merger, with a person or group owning 15% or more of the corporation&#8217;s voting stock for a period of three years following the date the person became an interested stockholder, unless (with certain exceptions) the business combination or the transaction in which the person became an interested stockholder is approved in a prescribed manner. Accordingly, we will not be subject to any anti-takeover effects of Section 203. Nevertheless, our certificate of incorporation contains provisions that have the same effect as Section 203, except that they provide that each of TPG, UPMC and The Advisory Board and their transferees will not be deemed to be &#8220;interested stockholders,&#8221; regardless of the percentage of our voting stock owned by them, and accordingly will not be subject to such restrictions. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for the Class A common stock is American Stock Transfer &#38; Trust Company, LLC. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Listing </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A common stock is listed on the NYSE under the symbol &#8220;EVH&#8221;. </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_396"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PLAN OF DISTRIBUTION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders will act independently of the Company in making their respective decisions with respect to the timing, manner and size of each and any sale. Subject to the terms and restrictions set forth under applicable law, the selling stockholders may, from time to time, offer and sell, separately or together, any or all of the shares of our Class A common stock beneficially owned by them covered by this prospectus. The shares of our Class A common stock may be sold in one or more transactions at fixed prices or prices subject to change, at prices related to prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may use any one or more of the following methods when selling shares&#58; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through underwriters, brokers or dealers or agents for resale to the public or to institutional investors at various times&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">in one or more underwritten offerings on a firm commitment or best efforts basis&#59;</font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through negotiated transactions, including, but not limited to, block trades in which the broker or dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through brokers or dealers, who may act as agents or principals&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">on any national securities exchange or quotation service on which the shares may be listed or quoted at the time of sale at market prices prevailing at the time of sale, at prices related to such prevailing market prices, or at negotiated prices&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">sales in the over-the-counter market&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">in private transactions other than exchange or quotation service transactions&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through short sales, purchases or sales of put, call or other types of options, forward delivery contracts, swaps, offerings of structured equity-linked securities or other derivative transactions or securities&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through the writing or settlement of options or other hedging transactions, whether or not the options are listed on an options exchange&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through offerings of securities exercisable, convertible or exchangeable for shares, including, without limitation, securities issued by trusts, investment companies or other entities&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through offerings directly to one or more purchasers, including institutional investors&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through distributions or transfers to their respective members, partners or shareholders&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through ordinary brokerage transactions and transactions in which a broker solicits purchasers&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">in &#8220;at the market&#8221; offerings as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents&#59; </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through a combination of any such methods of sale&#59; or </font></div><div style="padding-left:72pt;text-indent:-36.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.51pt">through any other method permitted under applicable law.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent required by applicable law or regulation, the number of shares our Class A common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any underwriter, agent or dealer and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying supplement to this prospectus or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. </font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may also sell shares of our Class A common stock under Rule 144 or any other exemption from registration under the Securities Act, in each case if available, rather than under this prospectus. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares, from time to time, under this prospectus or under an amendment or supplement to this prospectus amending the list of selling stockholders to include the pledgees, transferees or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares in other circumstances, in which case the pledgees, assignees, permitted transferees, donees or other successors-in-interest will be the selling beneficial owners for purposes of this prospectus. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A selling stockholder that is an entity may elect to make an in-kind distribution of the securities to its members, partners or shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that such members, partners or shareholders are not affiliates of ours, such members, partners or shareholders would thereby receive freely tradable securities pursuant to the distribution through a registration statement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the registrable securities, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of shares of our Class A common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our Class A common stock short and deliver these securities to close out their short positions, or loan or pledge shares of our Class A common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares of our Class A common stock offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate proceeds to the selling stockholders from the sale of the registrable securities offered by them will be the purchase price of the shares of our Class A common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of shares of our Class A common stock to be made directly or through agents. Each selling stockholder may be deemed to be a statutory underwriter under the Securities Act. In addition, any broker-dealers who act in connection with the sale of the registrable securities may be deemed to be &#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities Act, and any commissions received by them and profit on any resale of the registrable securities as principal may be deemed to be underwriting discounts and commissions under the Securities Act. Broker-dealers engaged by the selling stockholders may arrange for other broker-dealers to participate in sales. Such broker-dealers and any other participating broker-dealers may, in connection with such sales, be deemed to be underwriters within the meaning of the Securities Act. If the selling stockholders effect such transactions through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling stockholders or commissions from purchasers of the registrable securities for whom they may act as agent or to whom they may sell as principal, or both (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be less than or in excess of those customary in the types of transactions involved). Any discounts or commissions received by any such broker-dealers may be deemed to be underwriting discounts and commissions under the Securities Act. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriters, brokers, dealers and agents may be customers of, engage in transactions with, or perform services for, us and our subsidiaries in the ordinary course of business.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriters, brokers, dealers and agents may from time to time purchase and sell securities in the secondary market, but are not obligated to do so, and there can be no assurance that there will be a secondary market for the securities or liquidity in the secondary market if one develops. From time to time, underwriters and agents may make a market in the securities but are not obligated to do so and may cease to do so at any time. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurances that the selling stockholders will sell, nor are the selling stockholders required to sell, any or all of the shares of our Class A common stock offered under this prospectus. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_400"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in the prospectus supplement, certain legal matters regarding the validity of the Class A common stock offered hereby will be passed upon for us by King &#38; Spalding LLP. </font></div><div style="margin-top:12pt"><font><br></font></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_404"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXPERTS </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of Evolent Health, Inc. as of December 31, 2021 and 2020, and for each of the three years in the period ended December 31, 2021, incorporated by reference in this Prospectus by reference to Evolent Health, Inc.&#8217;s annual report on Form 10-K for the year ended December 31, 2021, and the effectiveness of Evolent Health, Inc.&#8217;s internal control over financial reporting have been audited by Deloitte &#38; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><div id="i1f6bdbdece6446dca24b928102f9dfe8_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:48pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">8,474,576 shares </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><img alt="image_0.jpg" src="image_0.jpg" style="height:102px;margin-bottom:5pt;vertical-align:text-bottom;width:345px"></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%">Evolent Health, Inc. </font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Class A common stock </font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prospectus supplement </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.755%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.155%"></td><td style="width:0.1%"></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">November 3, 2023</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107fidelityprosup.htm
<DESCRIPTION>EX-FILING FEES FIDELITY
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i567690f506d7469687fdb1910495fc91_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 107</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EX-FILING FEES</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Calculation of Filing Fee Table</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Form 424B7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Form Type)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Evolent Health, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Exact Name of Registrant as Specified in its Charter)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Table 1&#8212;Newly Registered Securities </font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Security Type</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Security Class Type</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fee Calculation Rule</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Amount Registered</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Proposed Maximum Offering Price Per Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Maximum Aggregate Offering Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fee Rate</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Amount of Registration Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fees to be Paid</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Equity</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Class A Common Stock, par value $0.01 per share</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">457(c)</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,474,576</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$24.31</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$206,016,943.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0.0001476</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$30,408.10</font></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total Offering Amounts</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$206,016,943.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$30,408.10</font></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total Fees Previously Paid</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total Fee Offsets</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net Fee Due</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$30,408.10</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of the Registrant&#8217;s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#8217;s outstanding shares of common stock. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Estimated in accordance with Rule 457(c) solely for purposes of calculating the registration fee on the basis of the average of the high and low prices of Registrant&#8217;s common stock as reported on the New York Stock Exchange on October 31, 2023. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Calculated in accordance with Rule 457(r) under the Securities Act. Represents deferred payment of the registration fees in connection with the registrant&#8217;s Registration Statement on Form S-3ASR (Registration No. 333-266495) paid herewith. </font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0a06a.jpg
<TEXT>
begin 644 image0a06a.jpg
M_]C_X0^"17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3<@*$UA8VEN=&]S:"D ,C Q-SHP,SHQ,B Q-#HP-3HS
M,0     #H $  P    $  0  H ( !     $   0:H , !     $   #Z
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #D0         2     $
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M+4LD_P##G&:#RTLLOUF>>*/^K''P_P"![F)Q^B_6ZPO;C]3(+7:-R0 T@_\
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MOIL:UM/^E]C%WE77NO?LW-ZID8>(W&P69DMKOL=8ZS#==0YL.Q:V>E;=C/\
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M]4]/T_YS=ZN/NV_REXZDG8]_TOF_1_[I!?JI8/UJJ^K]N/77U:[[/:Z?L]K
M76-_>]K&V?H?])ZC/2_ZYZ:^<TE'C^8;_P"!\RW-_-R^7_JO\W_A/HW4,##K
M>13U.BZOL[TKV.C^56:G-_\ !DW2\+ZK-R:W]0Z@RUY< QEE=C* >WJ_HK-_
M_7K*Z5YTDCS?N^W*_O/!1XO8^[\7_,_I'_A2.3]OB'#[/%X^_P#^I?U3]*=+
MKZ=78 RWUL@\$M+0/Z@<%K+Y526;\,X?NXX?:JS7L<=?]4]W]9[G]YN<S?N&
M^*_Z]?\ -X/3PO\ _]G_[1>(4&AO=&]S:&]P(#,N,  X0DE-! 0      "H<
M 5H  QLE1QP"   "   < @4 %D5V;VQE;G0@3&]G;R!6,RUS:6UP;&4X0DE-
M!"4      ! _+?LY\T/^ %S[3K)C"5B_.$))300Z      #U    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    ) %( 10!$ %, 2P!) $X 4P      #W!R:6YT
M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 2P    !  $!+     $  3A"24T$)@      #@
M   _@   .$))300-       $    'CA"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T#]0
M    2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M 0!:    !@       0 U     0 M    !@       3A"24T#^       <
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H   X0DE-! @      !     !   "0    D
M    .$))300>       $     #A"24T$&@     #30    8
M /H   0:    # !% %8 2  M $P ;P!G &\ +0!2 $< 0@    $
M                 0             $&@   /H
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   /H     4F=H=&QO;F<   0:
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   #Z     %)G:'1L;VYG   $&@    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$%       !     (X0DE-! P     #F     !    H    "8   '@
M  !'0   #D0 &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_
MVP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4
M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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MNVP:AMN1;8^KU;?Y+;J[;O\ K_\ P;%U0_Q6_5[]F_9RZXYVW_E#>[=O_?\
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M\A[JD[CQ9 3#TF!J>/\ =O8LDN6YGD\L<.:8SXLL>/EN9C_E /FA/^OP^O\
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MFYS-^X;XK_KU_P W@]/"_P#_V3A"24T$(0      70    $!    #P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H
M &\ = !O ', : !O '  ( !# $, (  R #  ,0 W     0 X0DE-! 8
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M0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8
M,0  86-S<$U31E0     245#('-21T(               $  /;6  $
MTRU(4" @
M           18W!R=    5     S9&5S8P   80   !L=W1P=    ?     4
M8FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M   49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P
M ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E12
M0P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y
M<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M        $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V
M,3DV-BTR+C$
M                 %A96B        #S40 !     1;,6%E:(
M          !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4
M !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO
M+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M
M9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@
M<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT
M(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)
M14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ
M  !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M  !,"58 4    %<?YVUE87,          0                        */
M     G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ",
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MA!5U4T2T8/&C)18W".+CI&2%M287_]H # ,! 0(1 Q$   "?P
M           69Z.''*WPQP!>G1R[&FAV2
M!_/K>):\=OA.ILEYSKI,V3B#W6]2^[^?3^_5(<;JR#T>AYH\?KVR4=[QMW%7
MWEOR@                            69Z.''*WPQP!>G1R[&FAV2
M           !#ISO6_+O;U@2^L%V/VV/[0      *;X..$.F'@PMT2_;<Q+*
M5^%EZ]&2EE9&@L /HQJWB=NWK=Y1L+B6C9!H=807IN.9CW_6K+6PC&FR&W;N
MVWR;SG.@                           69Z.''*WPQP!>G1R[&FAV2
M             !R,=X<=XRR_2!UF])L@YFP'I      &*F!H/4[\XJK9N*O;
M7(F4N'PR=DWOQZ>/LAJ;KU^EFJ?]Y.L7&AKFX1]T^;KN+KC:QSKM9YUZO(2]
M(+GM9U8WHW]T?Z4^K^NV                           69Z.''*WPQP!>
MG1R[&FAV2                !R,=X<=XRR_2!UF])L@YFP'I     '\^/YJ
MDTPQKK0TEIU6AY:MQTM7HB7P5W>HVB;[JZHTNX56O_D'7>4#6.4!<:&N;A'W
M3YNNXNN-K/.NUCG7J\A+CXQGLU:L,ES6K[$Y]4K:D      >2^[KP\G?-]'Y
M^YA07H]3\78           !97HXX93_EMCN_,EHCNR3B>\  "S/1PXY6^&.
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M3ZO7"N]?Z!QE]^,:@"8%@NQP_<Z5P  ;):G[>H7IY>[X\W*#)L958F6;*^
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M@  >,S>-X5VT7\]N,WS$V1K<7)UR,D:_$2]P1DK'&^UGTEZS&FN3O>XSN
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MW1?[@@#\'-<VTI.CW(D6 ,[*YZLF8?OPQL'FQ(F_.!('QC+]$_5BY5+A^@"
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M=L!%7=78R[*_&>0;2ZF91?TK_%F2U@?;D
M                      #1YG+YLQ_<^_-FTN<UXAKG;/-]9_?4H[LK$7(5
M:,]FU^5V4E_Y4^G_ -?[V     8M3/1RX=QJ'BU,]&^+X;_37<?\C=V[NKL9
M=E?C+KKD=A']._G7)5^SFG^?-/R*
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M])=U7Q[W%NNN1UTU:,NNJ1OF7U TXDJ_;_5BK=?8
M    /&)#KY,F[./>P%HMD8 :F+O'PF-@ZOTSM1;Q#+SY6A,TP'90  !$FS=7
ML.I[S1_,G1'3VT_O.5<+Z (&.RE3VSTB0DSXBG  !#+SY6KSZ.4P'!5C CEY
M6AH_^38?H::N7$ 0R\^5J\^CE,!P58P  (_N>_G/'PSIH=0>NU6EWR%F>CUV
MFG:34I/^^$O!7L3>"Y<>^.XZKV>S]M\V=Y5VP])S5GW2ADWQZ#,E^'S;E.?S
M_.T#)C7/)\QW^2/['^@TCJNFK1EUU2-^SG4]F_\ 5E\T,V\C>
M              #QB0Z^3)NSCWL!:+9& &IB[Q\)C8.K],[46\0R\^5H3-,!
MV4  "B=GYRE]T:!TSM1;Q&=R[!^6^SKFTZ]V@"!CLI4]L](D),^(IP  0R\^
M5J\^CE,!P58P(Y>5H:/_ )-A^AIJY<0!#+SY6KSZ.4P'!5C   ^#L\\0W:OY
M%:T;YAVTN^0LST>NTT[;_P"66V^-FM7G/6SPL5LIZR^[VVDFK:Y66VN-GM?]
MG*'U6#^?YVBO0GOEW?RG?7?.K2S*=TU:,NNJ1MU5*)R[_H!T8V<_2?"0
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M9VHMXAEY\K4?_)T1LSJ'N &T"G^[=SCR4YRVU=,ZL>EU^^[C^@#2%D.+A5[
MUCJ(Z=WN!CLI4]8UO\&:=?\ 4 )UNN%KR'B^Z&7GRM7GT<I@."K&!'+RM#1_
M\FP_0TU<N( AEY\K5Y]'*8#@JQ@     #'2E9.U/ZS;C:Z,19/Q/QW8JS2?=
M[#ABZ>@TK\NZNQEUUZ-]/]-6RNV'PKF-N;@/+W?S ->M<6
M              /&)#KY,F[./>P%HMD8 :F+O'PF-@ZOTSM1;Q#+SY6H9>?*
MT !( QE+[FZ#)8(V3RSN];K6 !\7+\XWV^6-^N=H_D.%CL!68LN9($ #K-Z3
M9!S-@/3#+SY6KSZ.4P'!5C CEY6AH_\ DV'Z&FKEQ $,O/E:O/HY3 <%6,
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M,(\@$K6[[J$$,\%I'0(J)NMWTF1%R1:-<]6N+6[J/ZP;.B80&5%$J6")EM'
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M(M0C^K&KI.<J9.Y:FX'#%E@95.+6]1J="+Q6W-UE'GK<L*D5D05\UJ:\KHR
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M)30$,DW4N-UMWT&[B&C4&C4&3,&S<I2V@V@(Y<FGZKR6G5_Y*V%BI!7@JZ1
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MSH?ZZ0<3BL[\6WB^$N"Q\7N\UQ-%PBME<+C@F0:O%. X=+$;SP+NVS;H;\#
MSIF,# H4%S1Q-&3'J4&@(4(</5(05=>';-GBI6H  $L%KNK7]H<KY,F8-FY2
MD<.0;-SJGM6V6H=%SA11!Q?Q))]J*OLO@MQ\:W0^!HL?%\.QLTW_ $YV[KH&
M3Y(Z@4=#><2,,@+6ME?8%Z/BGBL?%[O-:V=^+;Q?"7!8^+W>:X[3/"7*KQ3@
M.*?#+O<3&:KGFN8ZE!9JUB+A$H/VZ?!.#+6<-%2:VG^"(A-:\9VI'LRXSE"/
M:-K)LP"I8F7GP939 HF-]HG*Y%9RK1LW*4CAR#9N=4V<TG1<]ZV>M8W;'6L_
M$TGVHJ^R^"W'QK=#X&BQ\7P[ $$4P*@)95JMQR+0K@6[,K_Y1+RM_P!(7ULK
M[ O1\4\5CXO=YK6SOQ;>+X2X+'Q>[S7&$*( *PWF$Z2$X#BGPR[Y^*??_P#)
M^*42[HE$XJ\,]7*Y4%G-_,G*18R;N@;-RE(Z<@V;G5-04)2EMZXEBV:;'XHD
M^U#8$S)3Y(FH^2)J/DB:CY(FH;5J3" N70^!HL?#\9 KRCY(FH^2)J/DB:CY
M(FH/E9D3VEI6_P"M%^[C@]6(,(RH.BJID$@Z$%1(F$P]I97V!>CXIXK'Q>[S
M6MG?BUZ-FMV(_P D34?)$U'R1-1\D34,-D"LV+W>:[!,4CJ.>:3S3724#BGP
MR[Y^*??_ /)^*42[HE$XJ\,]%=82F^E9[YPF[_+1LW*4CASE!LW.J9\_*4MN
M_#8VL*?XJD^U#8\RQ3YW&H^=QJ/G<:CYW&H;5UC"^N70^!HL?#_>QIG1\[%2
M/G8J1\[%2/G8J0>-5'CL=\,- DW&T_%_WB<NEG7!^\2KR-_]L?TLK[ O1\4\
M5CXO=YK6SOQ:]'-6TT?YW&H^=QJ/G<:CYW&H8;W%>47N\UV)8R9)F&/= DL3
MI\,N^?BGW_\ R?BE$NZ)1.*O#.+DW.8EHFGF5G>\,D3ILW*4CASE!LW.J9PY
M4)5AIMX#G1:** J/Q5)]J*OLO@MQ\:W0^!HL?%\..V[?]?.:NB@2CW+:4>Y;
M2CW+:4$&ZA)8[H1 W$A"A" "Q97V!>CXIXK'Q>[S6MG?BV\7PEP6/B]WFNR$
M#H%H;-U7,T*6?<!H/H"?BGW_ /R?BE$NZ)1.#(X!4OD9N76AM4#>R_ESK\N<
MV;E*1PYR@V;G5.W-K+C7J<N*^ [$L5/\72?:BK[+X+<?&MT/@:+'Q?#CM:W_
M %*V[I.013<G[HU'[HU'[HU'[HU%KW!-;;5V6_ZJ<$65]@7H^*>*Q\7N\UK9
MWXMO%\)<%CXO=YKM%=M$%4<G>^_-N)-/-NR:_4W7^Q7?1/Q2B7<;.DT\N^,O
M,;;>T74W9FVGTWKRSOK?.9DS!LW*4CASE#;:CPN"M61VQ%I4$8=NV/;!O?C"
M3[45?9?!;CXUNA\#18^'4RTMWQ\EVM'R7:T?)=K1\EVM#YMPAME 9J#4Y'"Z
MUL-M-VNNL2O@MDO^HW,_F_[Q-J+*^P'(PD-TGODZTH^3K2CY.M*/DZTH7"8*
M<MQ8^+W>:UL[\6WB^$N"Q\7N\UVSIMVS7G0ZL3?SU*33RD8,&\A\CD*I7R(O
MJHPON==7QC1J#1F#)F$5GO9Y#,W O(AYUVXVT[6H53/8K,M\D?C23[45?9?!
M;CXUNA\#18_BNY\'63]J7K]B<-'B"_26_;5E?8'"Z_BF+'Q>[S6MG?BV\7PE
MP6/B]WFO\%Y>QKE_KNC]0S#/[[->:(>1_P #_]H " $#  $% /PT3P:A^/\
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MT).%TY.BC@*(IDQ(-")4RJ1"$Y&$"NF0@=85>I W43,4U2JI@3P:A^/086D
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MF+*P[4H41C0Q,Y!4U^:"QF"QF"IJ"YCE  \JH+F/RS*FH)G.4$SD #\X '@
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MJ)9(0@?(JI'L<J,K;'896;W.-RN[>Y1?+3"&U@EL<9R9."9."9."9.%ZT_\
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MC]IC:>S5DUUM[B2+6I36ZMV6M,Z5I6E33^07.U-L7\-KLZ%=9Y975$4<99B
M.3C.0SQ/L[[N-E?ZA>"H^E7 >.V!XTB&K-,.5C".$:XP[=K>TUS<VI-1 #U=
MNM#4:L$>K%494<J7-!K,3G@D#!RP<L&P^[/L#M':[JVJ\D,>K;Q,14":[D*6
ML!(T==,E>#%O>_>E]X.SMB6YH3;V<;7]S3*J.Y:WMXV.?2C>Y49&C5($3;>L
M-L]H+@9GZ9?/$A:G FSULB%!S"L[\3%QIC79GW&]FF* 4:XL8;MQ2E")+M9W
MUAJ@ZVMK5J:U)KU%E]VVP(8:UU4V?:(M3I-%A KEGA$O_NS[/SHIJ!)LZS<
M\8#0FAYL,NT/N,[-I72;:SBLFX<]:S$#5SS-:G+/(8ED[,/MSL_=Z4^C7AN(
ME/!K)?)<RLHXEN(VJ!TZ5!UONQ^]'9G;?LK%HV?M7K+6Z*@T$<$LCS(A5<@6
MOH80:'J".B+;LE][G9':/8GMO)DD&TT*6MRPH#]"VA1;:Y6I %"C,Q*HKD$_
MAJV^47QC>7/R;>(_@/8?V.']&N\[2?[A<?IG[O-LRU VAVKU<K=&HD1.@W$@
MKJ<?5K64Y5"*P?!O.T^U6DA5B8X$Z%O#6N4<0-*T--=M:1AY3G!RP<L$$98'
M9O[N>S,U_>+0RR>1;VZ,31[F=J1Q*:'5#-KN05B5VZ.+/;OWQ7([3=J!1OHP
MUX]F0MQ:G1FO"I]-.4A<&C6N53:;'V%LNVLMD6Z!(H+>)(88T&A8XHU5$4<"
MJH XL5&\H<5&*C<NM@]JM@V>TMASBDEO=0QSPN/71RJR&G 2*C@PUS]S6WWC
MV*#7_1=HRR36:CA79]ZPEN[#C6&7Z99Y"**&T5FE6;9FU-FW%AMR$ RVMPH6
M5 20&!5GBFB+*RI<6\DMO(581RMJFGX7MOE%\8WES\FWB/X#V']CA_1KO.TG
M^X7'Z9^ZM)(P5%!))-  -))X .$XNNS/W>W>J@JDUZND\!6V/ -(,^DZ8J"D
MADED8M*Q)))J23F22<R2<S73@Y9X.6>#EBR[:=MWFV1]UVL&5@ +O: !S%HK
M B.#*C7<BE2>C!'*>L:*S[)]@^SMMLS8$&B*%::S4 ,DKL3)-*P UYI6>1Z#
M68TW*'%#BHWE#BHQ4;E1HPEKMJS#O'K&*5>C- S 5:&09H30:RYI(!J2HZ$J
M2[EKG9)/1G5= X!,H%(WT"HI&Y(*$$F-.[$6&SYYS_9QL_O0<:R]GKD#E35/
M@:A\S&L_9ZZ(]:A8^!:GT>#&K?6$T+<4B,GO@/Y5U=I;22R<2*6/@4$X!C[.
MW8'KHV3WP&"Q[/7-!Q+4^ $G!:]V/=1*.%XG4>$K3OU[A;?*+XQO+GY-O$>X
M=59VLDLG$BLQ\"@G%4[.W8'KHRGF-0XUF[/7-.1:GP DX)O]EW$(_M(W3WRC
MNRQQ(6D)H !4D\@&9QK0]GKO5II:-D!YBP6NG@\XXUF[/7)'(FL? M3YF.KO
MK*:&3BD1D/@8 [_8?V.']&N\[2?[A<?IG[H !4G&T>QW9V8Q; BD:.>12"UR
MR,0P#*2/H]1EJGX4=(G4(7=.6#EGC9WWK?>QLS_^F926-A("#?\ J;BX7(BS
M&F.,YW1Z34MJ"XBM[>)8[>-0JJH"JJJ*!5 H H    H!D-Y0XH<5&]J,5&Y4
M:,/!<PK);L*%6 93S@Y'#[5V4C/L1VS&DPD\!X3&3DK'1Y+9T+=SCN[D?1-F
M-F'<'7<<:1Y$@\#,54C-2V%8;/%S<CT\])#7D4@1BG 0E1QG"I&@5 *  4 '
M(!NM'(@9#I!%0><'#L=GBVN3Z>"D9KRK0QFO#5*\HKB2[M_\7LM<RZ"C(/7I
MF0!PLI91I)71NJZFC U'.,;-VLFS;>LT0+#JTR<=%QHX'# <F/W;;_-IZ&/W
M;;_-IZ&/W;;_ #:>A@75O"$M+N(. H 4.O0< #+@5SROOH[Z]LXWN+N0R=-5
M8A!T4&8.1H7'LL?NVW^;3T,?NVW^;3T,?NVW^;3T,;,V%96L2,HZZ0JJ@U-5
MC6H .0UR1PZRG>1W-X/H5@V8:1278<:QU!H>-B@(S%<(SV/TJY'IINF/F\HZ
M<ZD\IPL-O"D<0T*H"@<P%!O&_P!2V1#)(?3A=5_G$U7_ "L/<=F[XZVGJICI
MY%D RX@'4UX7&G#V6U+-X;E>!AI'&IT,O$RD@\!WMM\HOC&\N?DV\1WRRVT(
MAV=7.:2H7EU!I<^QZ(.3,N$>[@-[=C2TOD5Y(AT:<CZYY<+!;0)'"-"JH51S
M   ;I!&6'-WLJ-)S_61#JWKQU6@8^S##DQ)=[$D:\LQF4I291S#*3VM&]93/
M!5A1AO?W;;_-IZ&/W;;_ #:>AC]VV_S:>AC]VV_S:>AN1;1[0L]O9-0K$,I7
M'&Q/Q8/%0N17)<B1#LK9T4*TH2HZ1]DYJS>V)W7@N84DA;2K ,IYP:@XDGV.
M!97^D "L+'B*>DXJI0#3J-HQ+L[:EN8[E<^,,.!E(R93P$<H-""!N;::YM8Y
M&$Z4+*K4Z'!4''[MM_FT]#"HB@(!0 9  : !Q;QG?9\#.Q)),:DDG22:9D\)
MQ^[;?YM/0Q^[;?YM/0QLM+:!(U-I4A5"@GK'SR [C-V)V#<4VK-'_BY%.<,;
MK]74_P#%D4AI2".KC(CJ7>18B0,'+=/;3MC9G_\ SC94XJC#*_N5HPMA_81]
M%[HYZP*0KG([Q16\$2I BA550 JJ!0!0*     #(#+%1CDWE#N5&]J,5&Y4:
M,203QAX'4JRD5!!%"".$$:1@7-HI;8D['4.GJVTF)CS5*$YLH.DJQW>SVPY;
M2S:R,D4)K A<H*+FU*EB-+:2<\;;V,;6S6S$TD8*P(KA5<@48"H- ,\=F]E0
MQI'VC:S>>W- .MZL_"1%LJEE((KPC6K16K>]H=OQE=A[.-74BADF!Z$(!TG6
MIK@\BM0-4?NVW^;3T-Q4127)H ,R2=  X\0;8[10!]H'I)"V:Q<1<:&DY#4)
MQ%Q5>X3;<[-V^K.*M+ HR8<+Q :&&ED&3:5 ;)MS:79Z9\U^&C'(:+(.\=0@
M<K'CW@VA&M9[.4/RZCT1QX2C'D7>V6S[<?#3RJ@YV(%>85J>3%K96ZT@AC5%
M'$J@*/,&[)-*X6)%)).@ "I)YAC:6UI*TFE)4'2$&2+[5 H[VY!8V,#2W<K4
M51I)\0 &9)H  22 ,0W^U%2XVSD:D5CB/$@.EAZLBM?)"\/<&L=JVJR1<!T,
MA]4C:5/-D=!!&6 ]3-LF1J1R@:#IU)!H5Z:.!P*BF:KNVWRB^,;RY^3;Q'>P
M;<[11'Z$0&BA.1D' \G"$X572^ENCDR11(%B4      :  ,@!P =PFVGLJ-8
MMN 5-*!9J<#< ?U+\.A\J%9;>>,I.C%64BA# T((X"#D>X6_:/;D%9S1H(F&
M2C2)7'JCI13Y(Z1Z1&KOI+6956^0$PR<*-Q'A*-H8=\#6 .+BRNXBES$Y5E/
M RFA'XQD=(W-M_:$]YW'97V/]8_<+KM'(%;:4C&&RC8 B2XH"TC*:AHK56$L
M@(*L[0PME*2+B\O)WENY79W=R69W8EF9F-2S,22Q)))-3@D#!(&#EC8/8;82
ME9KN6LLM*K;VZ=*:=] I&E=4$C7D*1@ZSKC8?8_LS9B#8EA L4:\)IFSN<M:
M21RTDCG-Y&9CF=VHQR;C+>[9BZX:40F1Z\15-8J?94P?]$[/S7;_ -I(D YQ
M02DCG"][#+!V;LK=36AD$TAX=#"2-21EG0CC&>-9)+)!Q"'+\IF/FX+,]DXI
MH,.7/T74^;3DP/\ 4>S]A*G]F98CX6>8>9A4VQL*[M6/"A2=!SGX)J<R$\F%
M38W:&WDN&T1L3'*>:.0(YIPZH(Y<QN5&*C<J-&+G9E_%KVLJT/&#P,IX&4T(
M/ 1BYV7>"K(:JU*!T/DN.0C2,Z$%=(W.SOVR+WPQMS[9-^D;'W:WUG*4NHK:
M1E8<!#H1SCC!R(R.1Q96MM9BVLD^$D04'67#_&2&FD5)"5Z5"2<S0;D?:K:<
M57/U=3P#,&4CC.B/B%7X4([D-O[.BI87#TD4#))3G7D63,\08$>F4;FS-J G
MJHY '''&W1<<O1)(]< >#"NC H14$9@@Z"#Q;MY87 K!/$R-S,I4]_/+%W8W
M I/#(R,/7*2I\T;Q]HR+6&SB+?WCU1/R==ARJ.]NS6L;TNKUNJ''J4K*>;5Z
M!]F-R.&%"TKL%4 5))-  .$DY 8%Q=(K;;F7X1M.H#0]4AXAZ8CRFXP%IW*>
MQOH%EM)5HRG01XP0<P10@@$$$8-L27V?+5H7XUX5/KTJ W&"&RUJ#<MOE%\8
MWES\FWB.\_UK:<-=DV[]%3HED&=".%$R+<#&BYC6'<SVHV?%\/& )P/3)H$G
M.F0;C6ARU37N]CM^!*)<KU<E/^(@Z)/*R9?W>YMO[0GO.X[*^Q_K'W]ILVU
MZZ5Z5.A1I9FXE506;D!Q<)LJ2O9?9RFULAP-&C'7N#P%[F4M,30'4:-#D@P2
M!N$@8) Q-]XNU+:G:/M H,51G%8(U8@.$&Y<&=B#1XQ;Y!E-=UG=@$ J2<@
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M_6159!SQGI@>Q9SZW$5Y8W*2VKBJLI!![XX1H(T@Y$5WEUL]E'TL#7A8^ED
M.KGQ-Y+<A)I4#$L$R%9D8JP.D$&A!Y0<CN6WRB^,;RY^3;Q'=LMF6HK<3R*@
MXA4YD\BBI/(#BSV79)2WA0*.,GA8^N8U9N4G>3;,[,!'E4D-.U&4'AZI=#4]
M6U5TT5A1L,]]MJYDKP=8P7O(I"CF &%>SVM<Q,-&K(X\P&A'&#D>'$=KVE^'
MLR:=:J@2)RL% #J.&@#Z35CEB&ZM9EDMI%#*RFH(.8(.[+!,@:%U*L#H((H0
M>0C(XVALHU,2/5">&-NDAY3JFA]<"-^SNP" 5).0 &DD\6'M]G1/>S+I*$)%
M7BZP@D\ZHRG@;%?_ $XFI71UQK3GZK3RT[V([6]1[*Y;(&0@QDG@ZP4ISNJK
MRURP"#EO-I-0&2!DE7VK!6_(9O%N7UM_I/TGKI U>MZNE!2E.K>O/48_AC_\
MG_[&+&^ZO4ZZ%)-6M::ZAJ5H*TK2M!7B&\VELW_TYK_1[B2+6^D:NMU;E-:G
M4&E:5I4TT5.G'\,?_D__ &,?PQ_^3_\ 8Q:7W^G_ $?JH>KU>LZRO29JUU$I
MY5*4.C3O]O\ :%6U=M;8)V?:<:QR _291P_%JZ*PIJ/JY]*A.6.3!(&YV5[&
M0:P2^NU65ETI E9+B0<%4A1V%<B0!PXM-G6,"Q65O$L<:***D:*%1%' JJ
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MXC&Q4 \ZA3S$;^P_V]/TT^]V$Q&EI![J&1?/[^C<M-LHGP-[;C6/]I#1&_\
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M1- P&AE/I7&=#H.@@BE(]H;+N1)"=(T,A]2ZZ58<7#I!((/<7EE<+&HJ230
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M''PD>?OXKNRN'BNHS564T(/./-&@C(Y8CM.U$)5\AU\8J#RR1C,'C* @\"#
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M *M? 2YX:M0^3C9:2O1Y>TMFBY'-A;7STR&711C4T&5-) )SP<\L$ X.>/N
M@,K+3M?LIZJ:'X.\ADU>9M758<*DC%W%6C7$L<8]UUA\R,UY.XBXL;N2&<:&
M1F1O"I!P%>^2X0<$J!OREU'/?8X'TG8ENY]:SIX]?'\.Q_/']GBEKLVTCY2'
M<][IJ/"#ADN=LR)"?2Q4B%.+H!6(]D3@DFI/<9;78^T3# [ZS#4C<%J 5Z:-
M3( 94K08_?G_ (-O^RQ^_/\ P;?]EC]^?^#;_LL7%_>S&2[E<L[&@J3IR
MX@  !D !W(R[,VA- YTZCE:\X!H1R$$859IH+E1_Q(P#X8S&>^:GCKCX?84#
M-ZV1E\8?QX.IV?B#<LK$>#4'CPRVMK:0+QA69AWV<K^1^)DVCMF9XCI0'40\
MZ(%4]\;\,IHP-1C^(KSYUO1Q_$5Y\ZWHX_B*\^=;T<%6[0W94BA^%;T=^LT$
MK)*NAE)!',10C"J-K&>(<$P$E>=C\)^7@"ZV1:N?6ET\;/\ SX. ?P['\\?V
M>"+79%JA]<7?Q,G\^#@+(VU3#$?2PJ(_ P^$_+PTLTC/*QJ2Q))YR<SOOXBO
M/G6]''\17GSK>CC^(KSYUO1Q_$5Y\ZWH[V&XMY"D\;!E8&A5E-00> @@$'CQ
M_$5Y\ZWHX_B*\^=;T<?Q%>?.MZ.)(9MOW;1.I5@9&(((H017,$9'?)%9;9EZ
MA="/210.("0-JCV-, 2VME(.$E'!_)E _)P.KV;9 \JRGQ2K@JE_' I_X<:@
M^Z8.P[Q!P;C:%Y+//ZJ1F<\U6)RY-&_V0Q:LD*=2W)U9U5'N-0]_<>*!!_JU
MN"\!XSZ:.O%(  *Y!@I.0.'CD0K*I(((H01D00<P0<B#@Y9;ARSQ#>0>6AT<
M!'"IY",O-&(;N!JQN*\HXP>4'(\O=A/=1_\ E%J0TE=#MI6+OTJ_$@(R++N?
M=OL'7HUUM][BF6?T:TFC)T5R^E@9&F>8)I0YY8(!P<\'/'W&[.5=81[2GN3D
M#E9V-U=UZ66749'36FKTJ8V)L=6\E7F8<YU$/F2>'_M-M;8DC>4!,@Y11).<
MD:G>![VY/VLV/!P5N8U_3J/TH'RE/+.*C!RRW#EG@P3D_09#GZUO5><W&,^"
MA5E8%2*@C01QCNEOLO9\=97-2?2HH\IV/ !X2:**D@8MME6"_!(,V/E.Y\IV
MY6/@%%&0 W/NP[%1RU_T[8\]VP' U]<"*AY=6P4TX P.ALR <'/!SP<\L=H.
MULD=;+8'9JYD#4J!<7DT%K$M?2ZT#7;5T]"@%"2-JW2/6W1^J3BU8^C4<C,&
M;VW_ &FV;M0$]7')TQQQMT7'+T22.4 X61&!1@"",P0=!'(=P@BH.+G;^P(=
M;91JTL2C.$G,L@&F+A('Q?%J>348.66X<L\+8WS?X/TK>HY#ZWQ<VA65@5(J
M"-!'&.Y1;.V9 9+AL^)54:68Z%4<?'0"I(!%K 0]Y)0RRTS=N(<2+Z5><G,D
M[OWH[>M+KK=E07YL;<@U4PV"K:AD/"DLD4DX/#UI.50 <\'/!SRP23C[S_OD
MO(>KVGVHVP+6S8C-[?9R/#'(AXA>7%\&7+ZM6IR _"4<,2UD=@ .,DT \.))
MI=AR"-%))UX\@!4GR^+>P6%A 9+N0D*H(!) ).9(&@$YG$VT-H[)>*SCIK,6
M0@:S!1D&)S9@,AP[ES_H]@T_4ZNO0J-77UM7RF73JMHKHQ^X9/=Q?T\?N&3W
M<7]/'[AD]W%_3Q^X9/=Q?T\?N&3W<7]/ O=J[+:&U+A=8LAZ1!('18G@/!O8
M]I;-L5:S9B Q=%KJFAH&8&@-17C!P+#:UOU=R4# 5# J:@$%20<P1ITC>RW.
MR-FM- CZK$,@HU :=)@=!!PEGM:T,-RR!PI*FJDLH/1)&E2--<MX;+95J9KH
M(6U05'1% 35B!PCAQ^X9/=Q?T\?N&3W<7]/'[AD]W%_3Q^X9/=Q?T\?N&3W<
M7]/'[AD]W%_3P;':EL8;H*#JD@Y'0:J2,^?!LME6IFN@A;5!4=$4!-6('".'
M O=J[+:&U+A=8LAZ1!('18G@/!O;G_1[!I^IU=>A4:NOK:OE,NG5;171B!-L
M6+0-*"5J5-0M*^2QT5&G?_Z;.];VRHG*8C\6?:@%.0*I.G=[V)MK]E(U2Y.;
MV^2JQX3$="-QH:(?2E3DTMM=0/%<H:,K JP/$0:$'GP<LMPY9X6"<&2PKHX5
MY5_HG(\%,ZK/:3!XSQ<!XB-(/(<^X#Z-'U6SE-'F8'5'&%'IW]:,AEK%00<"
MSV;#TC0O(<WD8<+'DSHHHJUR&9)W/O!^\#KPFU+>R:&R'"U]<_ 6M!0ZP25U
ME< ?%1N<@"0[NY+DDDDU))TY\?&<'/!SRP23C8W9G8%F]SMS:-W#:V\*9O+/
M<2+%#$HX6>1U51QD8^['[C-ARH^S^R^R8+>:1,EGO2@:[GI09RSM+*<@0\T@
M(!_">S?M$?OQC:7V>3WAWNP?E'_1/C;G]S_U$6YVG_RWZ_%G_JSR+U^OJ:JE
MO(U=:M-'EBG'CX^X^:/HX^/N/FCZ./C[CYH^CCX^X^:/HX39^S))3<BX1^DA
M4:H5P<^^-Y9[.M%K<3R*B\56-*GB TD\ !.++9MME;P1J@KPTH*GUS',\9.(
MMLP)6ZLFZ5-)B<@-SZK:K<BZYWNU?MGZM,6'^WI^FGWC[0VFSBV-NZ=%=8ZQ
M9",N\<?'W'S1]''Q]Q\T?1Q>?Z2\C=1J:^LI7R];5I73Y!KQ8M8]K22!I@Q7
M50MY-*UIHTC'Q]Q\T?1Q\?<?-'T<2;2V:S&U,2+TEU350:Y8E^QR>^CQ%]LC
M][)O>T_^6_7X[._)S>./?VNT5J;8]"51Z:-B-;G*T#+ZY1P5Q#<V\@>"1 RL
M-!5A4$<A!KN=[<U=J6NK> 469*+*O$*T(9?6N&&9H <\27-A%]/V<,]:)3U@
M'KX<V'*4+J!F2,,K*00<QP@_STC<.6>.OLYRDGF'D8:".?G&%AVHG4S>J%2A
M\97OU'KAA989%>(Z"I!!YB,MX+?9-A)-)7,@=%?9.:*HY6(Q'=]I;@3S#/J4
MJ(P?7ODS\P"K726&([>WB6.!!154 * .  9 <V\V%]QFP;L-L?L_2ZORIJ'V
MC/'\%$=(/T2U>M0?C+J6-QK19'/!SRP23@YY8VY_\@^T=D'[+]BP$L%<="YV
M[<HPMP*Y,NS[<O>2 $-'*UFU>D,2SS.6F=BS$Z22:DGE)S/X3V;]HC]^,;2^
MSR>\.]V#\H_Z)\;<_N?^HBW.T_\ EOU^.S'^9_4=QO.T4Z?!P#JXOE&'3(]B
MA ]N>+&R]C6$Y2Z+K.Y&D"-JQ#ON"U/6*>'%K>,@:VNX"'7@J04D3O-K+C:&
MR9JDPR$*?5(<T;OJ03Q&HX-YM7[9^K3%A_MZ?II]_P!I_P#+?K\=G?DYO''O
M)?L<GOH\1?;(_>R;WM/_ );]?CL[\G-XX^X#LOM&7/,V[$]]HO&R>V7U(..]
MO&;;&QXGN#_6J-27D^$2C&E,@Q(Y,._9_;[IQ).@8?.1ZI _NVY\,8-FPW2#
MAAF3WLIB<]Y:\F&^D=D=H@#21;R.O%Y2*RZ=&>&238-ZKC@,$H(YQJX5]C]G
MMJEF.75VT[!J:>B$(:E,Z@Z,1Q3=@9W4^FD*6I'*>N90>8*.(9Y823:UU!9U
MTJ#USCO+JH>])X,)+>++>3C_ (AHE>1$I7F9G&(K>SMTBMUT*BA5',  !O=O
M=O;]HY-ON#;;,MF_YF_D5NJ4@$'J8@&GN""M(8V53UCQJVV.T6W;][K;=_<R
MW%Q,Y&O+-,[22R-0 :SNS,: "IR P<\L$DX.>6.S7W>=B=G-=]J-KW:6]O$#
M0%W.;R.>C'#$@:6>5Z1PPH\LA5$8CL=]TO95Q)LO9,!,TX4JU[?3$/>WS@]*
MMQ+E$KDM#:QV]O6D(_"FS?M$?OQC:7V>3WAWNP?E'_1/C;G]S_U$6YVG_P M
M^OQV8_S/ZCN$4$*%IG8*H&DL30 <I)IBTLI)%6.WA+2OP:U"\K\U:D<2@#@Q
MM#:TM:2R'5!]*@R1>\H /&:GAQ?]G)WR;X:*O&*"11SC58#UK'AQ9=I+>/IQ
MD12T]236-CS,2A.DZZC0-YM7[9^K3%A_MZ?II]_VG_RWZ_'9WY.;QQ[R7[')
M[Z/$7VR/WLF][3_Y;]?CL[\G-XX^X1S0R%9D8,K T((-00> @Y@X$-RRKMF%
M0)%T:XT"11Q'TP'DMP %:][>C>G<&%WFV>U7:C:D5EV>V?;//<3R&B111J6=
MVH"30#)5!9C15!8@&YV\G6V_8+9NO;[)M&.<<!8:]S*H.J+J[*K)-2O5HL-O
MKR"!9&.>6#4X.>6"JG#_ 'M?>%LLQ_>MMNVU8(94(DV5L^05,95@#'>WHH;K
M+K(+<):UC:2]B;\*;-^T1^_&+JV#4,D;+7336!%>]7'\11_,G]IC^(H_F3^T
MQ_$4?S)_:8_B*/YD_M,;/VP^VDE6!B=41%2:JRZ=<TTUT8VY_<_]1%N=I_\
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MAK6S)*EPPH5FN&#10$$%0LTP.M"H:.*)0L2@  9  "@ '  ,J8 )P,\L#/+
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M:*M !HP,\#/ SP,\; @U:,MG%7@Z112W%Z8GEX\\*B"KDT PL8S<YL>,^@-
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M=Y;^S7QC>7*\4C>,[Q;:Y- NAM(IQ'SL5^E)X<'JR7;D%!X33S*XDF= M'(
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MWU>S_:'7GR'12\4CZ4G)UA9;@$GI-+(%%(SCOX&!@R6^3<7!WO0P58$,.#<
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M8Q;^V]ZVY9^W_-Q)U*J=:E:@\%>(CCQ\5%X&_I8^*B\#?TL?%1>!OZ6/BHO
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MVQ&BQF&R-QPR$  5551$VRWI>Z&\RFXKHK".3CVH6NN-R'H&4ZMNAXQ%MZ+
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M)LG#9.&Y$\*[#PW;MWH>#ZZ_7VDQ$3<9M*3!+PY9 )S,DJ_X*N(B%]455-B
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M;A*J(L92%B%9UDV)8UMC$CSZ^P@2&9D&?!F,A(B384N.;D>5$E1W!-MP"(#
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M6>F0TD.785&F4:*_!TBI428W(!(LZBERLA;(4!SER'LW$WM(B?B'AG]5Z/\
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M6L[E&-":0.T/E$%?DO$I/RY)B*<SKI&X>[B2_NSKS_8QJC^0]YMH/_;-I?\
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:^T3^B_T6/_0OZ%_-!_1/^R_^;_Q-W]P__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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M_NE8B\KXM)0*DQ44&28F,SRP\2 >VC*$'3N&L7G37HR-IWC@_D.(:U0B*15
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MH)4BV6+N%V/.UA!G%#S7P64CXIC"Y0*-.O"/?_A5Y"F5$&9&$^,DQ(LK'W0
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MZ1J6>2 C(TU\Y!-W8&B,LS68143E""ZB8/ZW,#)8(5261SBC :^:0P]N1\,
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M60:HMA74M2A8X7NLBO;ZF--(TT7LR@>)SS]@M;SY@T=[#H4U<>+WY%D+K:Q
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M#]PS]&.!KJX:+GWB&O=CF;#BJ+">"G'D@H4H]A&&G-4"'-%H<;IBQ0*LM"W
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MQL)Z@L5=L2_O,0W]$J""PTS_""&.A!42_P8IL,O*ZRW-2;S_T 0^.SYJQ:E
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M3#\*-R@\I\":BU$<&IK$^__V.GSWECV8:$Z"2U50MLXXHM+!; LS9I<R#UI
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M!"L^P\M"* ^=BT6"[QF:$,(1^\X\ZZ$=V)?;-S %[7.8*+9\F2=X]XH!_-Q
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M'7UST;/%%<]<5&V&R:S [O$V$=).I2?%JO1HY7?@0)KCZN$,0\T"B25_QBQ
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M&IA;;A$+D;W;[?F\*7/Y/+KS@E:X<@%3XJ<&!O ^\^>&AOW/1+?FUS#_BC]
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M]9.F>1_W$ZWVRG/.6RU7@_,W[H)<GG<KR"&12/G5[3F_ZT$!>;^4V\_,5NS
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M\=KT+&;G<JBU62D+U^(C$O@8"UN'C\((PF?Q;@(+%_SAU_$Q#:E"$EGO7%#
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MQJ78<,/=\*,?_0KOO/,Q$NG:LL]C5U:FK]*1I9*V'_TQ"Z%#YZ1)4_&O?SV
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M<?8E9(4ZGLZ5PY[DX./^V>%]RBJVQ>E\C<3+\'?%E6<.I:7X:NN&5FZ?(HL
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MEW<O(&YRL6!BG\>_U2X.3X8+A<)Q%"XVKRZ3P6NO/8 M-MLH3*L@7@!%]#@
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M\2_46IX=A.44MO-/G0QD25 G@P6C3@:M*OC523?_\S\X[ZR?6L&NFV6T44;
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M3]"4-R=3(E6.F_H<&Z\Y>(1L*#<X./QA6'LZ=JBABRX\BYYX_*]T]MG'RY-
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M\@SK),X838WA\\#Y?HJ"_XH>I3'>VJKD_2GK6RY!34W-=..-OPO+NF6Y.9\
MBM-&-)%Q;ISAKV!SW&YDLQD*,NP3@S0%2'/;8<?V/_"]&,3F6A%Z,CZ:&#LV
M;44B@A-7'7:H,!(@!S1IT@PZY+.G44,C.GT2MO ]?@83D=$JIJV#P65V; CR
MDO$DC1XSC*[[SA?HM%..#A] D(8@ F6%H$,7)1C;#O1SZ\$$=#5.=77U'"C_
M@N[Z]W]IQ:I5_ OXNE,8F+C!5OYO8.6S6W00!41R[F3$Q531^&)E+3>\Z1P]
M\]Q==.A!^_ #A;+0<L9OM0SJVC*;ZX9>8W%4$_W]7X_0Y1=_G:@LR?TJ;)?)
MWHOO26<K?-YK$'QQ?6:;FVF?_<?2;VZ^CO;>:Q?.EUL6$WB.3I'&:,&\Q;33
MKD?*FZR)1(GN5/(Q@+UG<QFJ+*NBZ[Y]-5UWW962O[G/\!6TBS_^R1_H__WH
MQQ1+=1*[A]%+ERQL%Z.*M $H@YQNHRPVP<6"+8$EFR^0ETHFJ5MM9SK__)/I
M6]^ZDCIV:(??YGNN'/%?0QR"Y_5:LHQMIM@>I5PYB<$F+'8,.'Z^_?9_TXT_
M^@,M7[Z2V_4TQ;!#$>)H^8W"[TO[+E7!_Y&( ]W$-K@QO!J$=%,3#1XZD!Y^
MY';::?@@>:90[M!GV(,-=FXK7[OF1_3+FWY+\3+L#H,2]-_N@TR&1NXTC!Y]
M^"\T<&#?,-?X.&#2]LZ['J +SO\:ZU!2;)$-T'L=^BCRGEO<$OII.LY449Z@
ML?OL0;_X^;6ZN* (]6/XS=+IM[9)6C@QO7CG_;GTW1MNHL<??X'JZC?I)"7?
MB\>2<I91!;2[TO "OS589<UK:1[D8V.LOMV[T!MO/D9=NW2"VL*D&1VG,OX7
MW +40DR"-YO/.N=JFCA^"O=G4JQIJGMNIXTHX_12RRPL#3%A[MOP98SM4^YS
M5E5Y!8T<-82NN.1L.O^\4ZB\HDP>WQSWWY+_C&9%%E<&+<IW*]Q[WV/TFU_?
M0=-GO$?K-FZ0O'@\Q>J<127P?R#\74[+YV?"'3JTE*,++%C+@,N$VY8@EZ::
MRO8TY<V':?"@_OH0\U'E;RC//?<:??[B:VC1@B443Z*M]I>\Y7 "GPCLTK4C
M5594\"5L"YIEM!98:/"%*\ZEKW[U4DJRGL$^8<,VEO#A1&N1 23=JA4&M&9=
M'5U]U0WTKW\]2%3.01T_*V\(<D,9Q#)LPM&9L/A N%"PD*>Z+$F?/?)@^LF/
MOT4CAND@GI:M*Y_-"_F#\HW-:1E8()"&$]/@K)B_WOD?^NE/_TCOOS^+M1?;
MZ&K'#K^+Q04 "PU 5/06*V@1L,D@#!P_%T,\D:-=Q^Q$+SY_#U555?)3*!LM
ME])E2QGFSU],^^YW*BU=L9P2'.ACA2->R)"=#"+DM] )+V/_]+WO?HF^_8VK
MU&HL4/<>Z#MVVOF_[_Z"?OK+OU%S>A/%<]QFBZWXCTZRY:A'UV[TXK/WT-!A
MW%F%V7NO^OKMTL>>>('./NN+5-_8*&_LX_NE^GFGB)N_&^@)D9"6_Z"-E#?J
M\8=CC [<-AYR^ %TX_>OH5$[#0F?ANW@]W$4IXW_E4)<I_Y(K]$Y=6VY.Q-M
MK*NC+W[I!_3?QY^E-:LW<A6F9:(#-HZ!!:RFQSQ'+%[XG:@"&X>?AU;C;5,,
M-'.G5N*^$XX[@O[Y]U_)SE\H7RR,*1ZT:QEK&Q^$+3*P108?!RR:@FTN7[F*
M1HP\E-9OK%?[9+^5R[ M1MMUB2&Q"Q(7+F?.Z-F]&UWP^=/HAAN^2)7EA0DQ
MN<T_\]-@,ILFF<;'(2S&/.%UPZ8F^LE/?T>WW_X?6K)L)><5'G)O[:+-B,J8
M"G R%\N-2<-<4Y9N^-Y7Z?KO7"U][N(8QM@6W/A>RTF*3*:9_GWOTW3N.9^G
M>$4'CO5$\?@Y+EO$?)BLC9#^;8Y;Y"/EQL4 $V5MQ!U.<QR8)=;'<NK3NSN=
M=?JQ])4O7T1=N]7*[RBN[ JVK7DXD%><'T40*ZO-*P6;UGR4D^8U-Z?I][?<
M27^\]9^T<-$2VL3^$SLJNC*6%^"DGPD]U['IPG\WFG )\H\,Q>/8\0&E'5 9
MM_7GG'8LMSL_EV>V5D8MZ\1P1&F1@8 Y2>Z?]!_0B^ZY^Q;:9^]=PAO&CJ'E
M6(+9Y8=3:#TBB(O3L)OZ2R]/HG_]ZRZ*EV'5J 8Q4!X<6&" #G.403D@>.M:
MVXF^^:TKZ;Y_WZ(+#+@,,;$7R* UGG1K]! ,H\QP!0,T(_QP4'YNVT0''!D6
MMX27@NKFA9\[C?Y]U^]IOWWVHA1K*.H'((C#XH(H.D!LW:>R(K!5>T5YO/[F
M= Z"[Y)KO1<F\VB9MG5<'6\-O'5Z]CG'L3-+L]I 'O9;LIM%E!K F"RJ:*[?
M0!,G3J>5J]9P5E1DCS988( =/>Z]_TE*IYO85C#LP'80A?I'P,MZGV1[/^ S
M>^H" V1OZ>@\)$9SYRVD/_[I+JJOV\CNW4U>(/Y@^>-1*(,/00:$8 9L!_PW
MQW$LDK+ ()NC5"I!0P;VH9M_]3VZ[YX_A L,\#M\8#"3?TG;'4VW1-L9X\-
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M1QBXGW#16(K[:/OONQ?]_>\WTZ47GZ[W\[YIZVW'YBVQ\;_1LOS0J")'<[%
M^0QN>W_[ZQMI[#YC*,'7\DU>W(]0/*EMI()T\<LK\FUHCB>#3)Q^_HL_T:;&
M-.?BC>66OV=\$!J3._O6R=> TIF 7AL_A2:.?XEBR23?U?$K?=;*5N"BD'@/
M8_-2;O"C 96G$K3+KL/I][_Y/MWQUYMHV)"!7&YJSY@<"M#F2#&V+$,KVY;
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M&7SS%>&6;-/&ZA_CSN;B!8MHPJ0IW&G/A$\9I4_HVSZ AQYZDC(!US?KOKS
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MDG*3,O@ "GUP0\@7!][&3].DB6_1Q''CN#^CWQ;'IF.N+^/*SGOM$@&U3R-
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M?T>-C9@<$V7/ WTNCDVT_8TVKAQ0?B@.].W>GCF7'GC@OQ1+1GL\6M2#_6&
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M/\+C0GX'H<W*)#_6$J;-QCY=L..AU (JPM6+GIBXQIU<AWON/IJ^\;5+J/_
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M>@AO% )=K"&_A#**0-OR<9"R,[RG.+;2\9*6]M"P:1/==NN_V:RXSQ3G>]Q
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MM;'<LD22OG#E>900PW/EXC]8(/K>[/F4;6Y07Y/+HO'AOQS+1>#-!-0R%M2
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M^/1PZC5\Q#!*<0<B1^&*;$\F@3X*K$J?\9;N9. E4L%:EQ*GA]4Z8L1@.O#
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M9_=N7>GI)_]&HT>-D'M1Y+GGQH6+#!9':I%!WWZ]Q,<><LB^>L,PVB EN,A
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MN8_&[KT+"B&\4]HL6;J"QAYP*BV:MXAB"7TA#+(A=O(5R)B*Y[B??R'W;VY
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M$&))>O*IE^B]]^?*9<O)=NA1\77;!O_VK2T6R.>%ISOOO(_6K=T@D\C.7'Q
MY,=9+YF6@E55EM&IIQX57D'7G;ZS7IBO:%E:L5BXW3C\J-J,SZAG"(V!Y:VN
MJF!]J0COFFX8I02L%78+?0ZS/ ?>J:6HG!.5A5$?@'DMO]!)/=5T24=<OPW#
M:&7@8[BC&(MA03JB"DX',>H_H#??]-?_6-MI&(:Q/8%7C9YGE5#=6A2CC5/B
MK^1:9]@PC!T!FG-TBM$YMH^6;H$$/.R1<SGJV[<7G7;J,9R!'%EF@">\15LA
MZ(:^OR\#*(DRFCKY+9KVUCMRM_CM#)VD*:TR<0/1Q8L-\C+Q:>FRE33I]2G4
MU-1$\;C+E^G5DJ=0=^$@/".3;9Q&<9QP_&>I7Y]>DBOW\D4$;2B45U0IUH'&
MQB9:M'@9I\+0T_<%2"R>.U 0L)\@9^V'81BEB;5H?F/U:QA&J\/]0_G\$/I1
ML4#Z2H,'#^0;_GH@\ZV&81C;$WC5Z'E6C#/:^*+1UBGQ10:&81BMC[R=':!3
MC'-6\HHG7*,,2J$XV"DO+Z.]]QQ-0X8/I5PVZW\8!)W #"(6G\@"%'U;NZ%N
M [WTRB1:L7*5/L>HSFB)E(K^Y"?6PW_OUO[=_[K[(5JZ;+6D<[DX2\C/\.]A
MO46IX^3' B.17;[)C7- 2:[GKWWU"LY7GZ"X2>3"HH1(4Z0OFS8UTIPY"SBE
M9>-]Z13;"J<#/HI5HE1\@&$8AF$8AF%\$A#[!P%V,= A:/G$'N=9/&P8AF$8
MAE'ZV"(#PS",CT0[O^@(M^]0(VFC@)0._W 3:(,&]J533SF***CG*[^G$N.A
MT/EO->/[DD@G*NC)QY^G*5/>UOQP *4P\8QK]TNE@.[6L#4>?/!IVKBA3G8Q
MT!>U=4(>T\BE7OLB1PP+)W3Q@*LQR#5J]!#:?;>=-".G@V0Z6!9FN42$D1(H
M^I!Y"QWR?"<#2 T5*%8#TPW#*"W,4@W#, QC^^#Z2?G^53X>]KM/8!B&81B?
M! R=6;_4:.O8(@/#,(QM &]G)Q()&B1;^FTV619A4 IQ_)2W^#7LZ=BQ(QU^
MV/[4M5MWHJQ[L]M3\%D 405\:SY.^%H QDMBK"N+%\ZG<1.F4EU] QX(!U:T
MC$I-?_#/U0&AEO_NU]]\B^;.6T1!%F_SZR=%G)PY'[8R8$1N-R$>ATPQ"C(!
M??'JB]@GX*W\0B@EG\.0\Y9E%46D#,)BJ*BHH#Z]\=U5SWU""&07\?5'>%W0
MB>*T81B&81B&8?A*O@^,/XB!6W03+28V#,,P#,,H96R1@6$8QD>@$X8X$W7J
MU"',-0JX48)"D[+3R*%TS+%'4RZK$^R^HI*'$\I\X(UW3+3K8$F*GGSR)7KO
M_;EZ+QQ<T;,KL[:-^S>#XDE1EWWK;7?3ZM5K*);@NN<\?%]3%QO$9'OXTI#R
M(\AEN395OIC(1]2G=P\Z\XSC)"UU+=6/\E%?82BB/V&!5%55T,"!?3D5+C+P
M9!'*!P'91?[PP*XG;D%*L2T9AM%V,4LU#,,PC.T#0F(7_R,4SF4RDC8,PS ,
MXX-!TVG]4J.M8XL,#,,PM@E,$.4H*V]L&RW!!+IK3C!PD*,>/;K2D4<>2(FR
M,IUH\Q1YPYT/MYV^(&^S\Y%(T=3)D^FMZ>]J/N/3Y.*2Q4OHY9<GT::&1HKK
M'#P$U $D2?HA*^Q>96+9 LB7I1-//IRJ*\OEONJW'B(S)VT2.:2H'/#MU4RV
MB5,H(]A,--"%%G&JWUA'&S=L"',-PS ,PS ,(SJ@?Z1+T!$;YZC?("P^!E'I
M%1B&81B&8?A)B2TRV#SX+-Z.V ;T#<-H/62BB#UFD$V'&?D?!A 77"@/^.8Q
MHX?3'GON1KD,RHP?P#-R%/OKXG3IX2;4172^*)Y<CB?BU%"_D5Y\:2(M7[DZ
M?T_..7SG'[1M'7+_YKR<^/?R7V0_\."3M&SY*KX(OZF)Y;4Y;(+)Y:!/>@ D
M@4PBFIS;557199>>@QP^C&T%ZN&T/DKDV%CB\035;UQ#JU:M#G,-HQ2)FOW"
MXQ=H>14]HBZ_7SA;UEK-+_N31;*&81C;'W@9YV'0;<0Q;,C@,,=?S*L:AF%L
M3^!5H^=9,?ZJHY*&T78IR44&[JW8O'GA+<,P:1B&T3J@28]3WSX]PVM@G@?
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M:;1U2JHGZ0:UXORO[M&S.Z<P4.TZQ69NAF&T$AA_2\1IX*#^888;;E;_8V#
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MMO>A.['J(G7XH4&#^E(09#D/67C"3ZSM- S#V)[ JT;/LR)\=^/JAM%6B7&
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MRA/,GKV SK_P:S3NY8DR6>ESW"8@;HVKG>!M\';MVM$O?W$=77S1&9)G&*4
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M6#/4^Y4,_#W?[=N[3P\YXM*>DI8*:X-T2"/3I?X"@-R*?U\AJ;Y0-(JIO\_
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ML1Q4?F@#7:/"7OL<C0?O?QJA@CP)D5P,D,LDJRK1;U _O/S"/6C9HJFFJ<_
M<F'AY7;Q*,>?. Y777$=POFE>IX+Q9*,Q]&S5S<\]_3MZ-2IO9>:>] U]%6$
MOG92XR>7\/T/OV# @*T02R94)ORGQ&BC0@&WRX1WQ]732AN4X/2Q_\4I8P]3
MW<'B<7ZVD;LDW<1GM@EI!S/_F*V3P!<O6J+MQ&]30<5O^=VZM$>?/CV]^\VM
M-C%I\E1T[C18[&:9E^+*)<BED*R*H5>_'KCRLC.PQ>8CO53#6/V4-.R-BHI*
M[RSX<'7'A@U*<?&XDW'8H7MYJ0:A'W;G78_BH(-/%L<THGZKT[V^90HN?DQ/
M5Y1]1IQ(7UH4Q377781_[[V#]_ 5\?/Y_0-^V>26G396+X&:9$ R#<81C\=Q
M_P-/8;__'"G.7HF7&DR<$B4<0.61;%ZPGXS'T*A)$YQQVA$XX;B#Y1H[].52
MT*,=8X5YX(&G<=%EUV/1PB4J&Q&1C63(R5)]5Q(JY=I >"_L+).49%B?C!T^
MK#\>N/=:YC#J%1F-]]GGW^+HX\[%^+?'(YQ7I/6KKP,0ZKN&X[WX9CK[F+AS
MMSQE*IY$PR8-T:A1&>*Q)&;-FHVJ6%PGU]'99'GYG9]ZQ,.L[ZJWT,:Q[UON
M)5DU'\^_^!@VWW2DW+?7R6?4"S*^6V:"Y+OC/\%..QZ /V<OUB<'W<"%Y-%=
M &3W+TCQ'CDCW9V)3I.VG*A$ZU8M</--EV"[[3;6*X;Q5]S_T+,X\( 34944
M_X=ZWVM*N0KU35%A/O;?=V?\[W\7>*D.U44L'#,?-LD@AR<9D(Q=9LVSWX!/
M*KN^E2VVV@=OO/6Q\S%YF7EXT9T$&LY3#X63G*N%7KVZXK:;+])5U0PC8S^<
MMCSZV#/PW//O()&0]#"CL6!K4-46B23.//-([+?O;HAX,6@NQ6,VR< F&1AK
M#IMD8&3SQNOOX:!#3\4O/_\J.CA/7=+Z/Y*Q?%Q_L'>/.O:G3BJ2E17HUJL+
M'GOH1O3MVX,771:62=HFN[$>MQG&JB%PDPPR^!W524R;-A-]!VR#N?/F!]C)
M%1?>ZY#6.^2A_/CWRTI.Q6(8-+@/;KCN? RK$0QG.A*,7&3QXG*,&;,;/O[L
M6Q$&OL>(L]W8AKCQB?\ J D:7>)-G$ J@D@DB7$7GX:Q)W#BC5$W\66/]9=]
M3%2SH;(RCG&7W(3SS[Y8'$J^BY_NI,L;!*U6S7G,0M-YP![/I.O(2279?N5:
MA%U9>7(@.3B3ESK>*Q,>D9"V;W=4G]$[2R8Q;$AO//_\O6C2F!T[;FC6J.M0
M)KEY0^GJB_ HA"E39^"$$\?AT8<?1SBO1'T<-@/*O9/=S.<"B=R>MM4P5R'A
MN=?&JRHP9I/1^-^UY^@ AV$LFP0F_#0%FV^Z)Z;^_@?"$:?K*5>^/<A%DA(/
M=5JW(VZY\4)LNND&FN9T#UN8E(UVTFAR3F.3#')SDH%J!OG%%;#2MEEL+E?-
MTF-)?N+I%['+CH>(;>:*.M)FY)*N9* Y@@WU0Y*Z(IE"-!+&5EN-QN,/WX2\
M_&A.M!'CKW#MYH,//\>_]ST.$W_\64[9=G*B=<CME^/3+]_"P+Y<MCJ:UB.Y
MTC9LDH%-,C#6'#;)P' X+3MITN\8>]HE>/2AQQ'*=P^>:>=1P/&];[]OUYU+
MI%]5CA-./ RGG?)?-&G*E4%YW5USY(IE-M8D >N==8W*X3>6$)HV:8Q]]]X6
MJ7A< V/"YN34C21(L%C_58_K%$NK"#G(GC3 HU TBF^^_A'7WG O%BTN=Q?\
M.\_*ZP:S7+K_;CDC*$A=TCL1DO+CU^PUU]V/[WZ8)'(0%CG)0T1D):Q;GFP1
M[[C^;I3]<#1?]B&$(_F(Y$4D[I5V'XI@C]VV\DK!J)NH]G*'U8Z).^?2^$,&
M]$+;=3H@%8M3<>G8>E!45VT3#(BFZS4I!_G'I_==>^4282+C6@B:42YGOH/'
M[KQF>=9CXA78?[\]T*"T2$[D[I919D9=H[H,.K_%G;=JU0R[[$+]++9*)Q;P
M.G^Y ,F]TB? R+WJN[ YX,E-VZVDY15@_#OOX::;'\2L67,UJY916N1Y8/(?
M=*I5M^?791*=[QY/A'#@@2=AZI29XO^X*RY+.F- X?VY"0,IU1<>VHZD#84C
MZ-VS*T:,&"QG[KJO>U33N&Q&#:Q8<@-M"5K9F1K/ZF'0"06;;SH*W:4-:>L1
M.Q66)L<<?C]+D.&$1W;D<BG>>#R.UU[_ .=?<)U><Z5$_5.S(&I+,^HOK,LL
M.ZJ'DN;%9.65E;CHTIOPV^3IXK/EN_Z("/M4JO=/U+<MDB?WX-V''D?#[EJ$
M?2SB9$CH.7C(,/3LUEEMJM,CCJS#G".7[]TP#&/UX[1LNW8MT:]?-SE:(BD2
M W+)J1R O6+<_#.6AJ9%"W#G'??CM3<^=)=X1?N5O%/-:1BKEH#UT&8W$O\X
MA+S\ NRUU\YR**W)&W3)#$ $J6']Q;V(IU\53^#IIU_&U=?<[B=ZOUD>;F.G
M-F$1,4"PP9KZ3[7!!R_B<\8(^.C#SW#GW0^B?,D2M\2X7J$<\.I?R%1](I34
M93VI ^AO1")A;#!B/71HW];+8-1G1HX<AJVVWEADO5SEE[+NOR<V)Q"Y=O?M
MDWWO =?A<GM%Q452_V-T@A3OW>DOHWY0>UWE25WV[]<#PS<8B52\4J68.;WU
MFH3<K&/*=E4BA?ONO1_W/? D8O&XI+IEK/VV[JR[$618PSH1F =:^3QVK\]Q
MX5T(AQQ\"MX?_S%"^:(3/3/@L@==/O0NY3ZE'+R)!5HNM)/)%)HU;XK--MT0
MQ<6%7EX6#K>@E\L_PQ,A(V?(;@^98[:ELM)B[+[[#J)VW"OH_&GK@5<M@G>G
M^G!Z)!I!^>)RW'O_DWCZZ5?UBBLKKV=%]3$W=G0'K-LMIW%U[./B+SZM[]+O
MNO,1O//NQZB*QYR]3;G^A_J.;T?]8[6Q/DP7,=]N^\V1G\]8C"MADDPYY2KU
MO^8-PS#J*M2P3LOFY471MT]WM&S;&:D8_5.WBD[N4-W>AL11G3-G$<XZ[RI\
M\MDW3)%_7M^!E@Q]4[-0QJHE8-%.]4;E CNYR7 (W;IUQIA--M3WA#%5!QNU
M35'Q< E G@0<N?%P*()%"Q;C]CL>P>-/O)BYH+CR\\M-8R(]K%ZN1OW#[_1)
MI4)>?RME/J+U.^Z2&S%Y\A1)<YE<Y[.$RYX<! &]HU!"[U_O3S9V_^RXTV;>
M5:/^XNJO<>,RC-Q@,,H:-==!!%%VJMN-8,.G5%.Q*AQXT+_1LF43:=IBTP.D
MNW*=#NNTP\X[;2DF:X$$2M3=M$VJT:7ENU>#Y"+A2!1SYRW!I9?>A*>>\@<V
M!"T;V:0)6"L(.%+!SE]C9P';@JM[EP9<?M6M>."A9SBCTN55G\];\CP7="3]
MW?1]IES<QZ-X)=JT:8&]]MY!SN@CN/+20C(,XR_Q=<PAA^PIOG=#;6=L/2Z^
MTDO!AH.I[#_B?3.N%-]DRM3IN.+*V_#3Q,E^)BD3R2?EX?00]8_IF.!07= I
M^VI?)?FKK[_'77<^BOESYH$KRV7;H:#@ZX!4DG(NQUS*1([RQ#?=?[]== ).
MANIE91B&81BK&N>) MV[=<:@00/%]E9)"NUR;OM>D;PB?"]^R957WX'I,V9)
M"@VT'__ZFV&L.JJY@$$@X\@[!]@_+RDIPC%'[B_MJ5PNB+J1]+ W^]8YRL%O
M7/YMAO(B^'7R[[CBJMOQP4=?N$3!%97WY(^7QK+)+D>C?J/UF=6I>MGE-^&-
MMSY&/.Z>1.&63-(8N^LD^[A>P\$7$6/__HJ*BK#SCO:JA&#@]-/  ;TP>%!_
M("%.I0ZFN!\CN/@=O/OOMROR(WF:QO9M-BL8%!;F8]2&@]&]9W^DJF):WVSN
M5KLBYWGYF#%M)LZ[X!J,?^\3+]';R=XT7R[ 6N;& 2_9L7T(;[SY(2ZZZ"94
MQBN]P76^*]QUM+B!KQR1#IV4I =J$S@!L:QA8VRZZ0@T:]I8TZE-W*OA<J1,
M#&,5T;9U,VR_S<9(>@]P)*5]!29F7"Z>!^+Y(WS]2D)TR ?O?X(SS[S<6UW(
M:10=@M4R\<N%NL8(!I0#W\9(#4L]5XB?>OYYU^'++[X1\6#MBW762>\UGOJO
MIWBWJO:4\)ZYL6^%$PZXJF#K-DU$VJO'81:3&89A&*L'VAMG9VFE.G5HB_Y]
M^,J$*MD8'^>"7[I\^#JCIYYX%O<^\#06EU=("OT1*2\K&V,U4/^]W2SHP/K!
M;;;S2Z+2L#;88 C6&SX,J;CDHR+BK";=) ^7,0LZ+))0W#G^<LN??/@9+KW\
M%DR=.IT7M!@</&!F5X;$+T>C/N-W;+ N0WCM]7=Q\RT/8>'"18B$W9)V?AOB
MWF]#_K[^XV28'>Z\QU$CAZ)]^]::9M1WG,QVZ]H96V\]AE,VY9PZW7<XC<"2
M2&']]0>C2Y=V"$4R=CS79RT'B:Y=.TJ[WA2IY!+GN\E/]F3(7$4M>7X87W_]
M/8XY[EQ\\NE7FAX8DVTLG[3X.Y].59[\>OW-#W#HH6,Q9_9<+NBC\L#)I>K;
M)3G9(*4# D''K63D339D#$/=$8]CG?9M<,01^[E,<DW+1V,<=VP8Q@HB[>7X
MXP]"-"]?VH[89>W,S8%&Y'?*>OU(>N_A%*J2"3SUS.LX[;2+W67Y4;TC>S<-
M@WF]SQKU%E_&_;V:#ZW?$*Z^YE:\^L:[J(I3-B@!?IT[.0D:R91(MFSZX%8L
MB7_O\R_1 KQ?S^XJSO\P#,,PC%4.S:W\4I]+*"@L1*]>75%0W$CB7IO8F0J+
M#8Z$45Y1@2LOO0HOO_JN=T7*R_I+C=5 H$;6LQU8_SC;H6_4J &.^.^^0*)"
MKC/=6VJ7P6$N.+^\Q5!$PR .*L<D*'CQV9=P\26WB +6'()?7IK9'6I@9 JZ
M/E,]K@UAUNRY./N<:_4U"7[71W8;8+OA8'R0 F)W=^Z>^-3-D4?LIVE!#/IS
M$<IO04$^A@WMASY]>P+Q6#K="#!BST\Z^0B4%)?4T'/6MH-"PX8-L.56H]"D
M64L-%ME?JZ]$R87)H<M#.ZYE"Z?PZ<=?XH*+;L0ODZ:*SM.+WF8$%;]VTVHN
M',*T:3-QX@D7X*>?)B,<9?M@=[_SX54?>I-S<L$NZCWREKF3$(8KV!44%6+P
MX-[HW*&MYF&9N'C0E8>Y"X;QUV3Z!$+:D;OUEJ-5$7&@/3<0/>IUS#H](^4A
M_@A7-*A84HD[[GX"5UUSNUZG4M%)7JIC<D/W!AU_$K-6?5KD0WCZF==PQQV/
M8?Z"!0A%(ZX]L+IEIWTJ+F/]1WQ/RK'*,@<O9*^K!#4JP3;;;HR(3O1W=VMQ
MF&$8AK%:4?>*7I;8(L_D].G=%4/6&P@D*EU"+B/^*5<:"T<*,/./^3C^A OP
MXLMO2UG1ES>?U%CU!*Z'MJ93FQW,12,1;+;Q!NC0H8-V-G&^$Q42<4^\!!U1
MO0R"I6AXO^%P%$LJD[CG_D=Q]OE7(A;SW^E:,R#P @FCWN*J+]/<CSWV/'SP
M\9<2)[)NF5)]ACV#83[IYI;9K?]D[HSM'EBW4QN,&3U44TRVZS_9LCMH4!^,
MVG"()"[6NK8.CN!"A[ESE\[8<,/!B(A]9U-V]4U[[E8L,>H_M$.#!O3!'KO_
M"ZG$?/52M&J]CMY<A:MQ\3W[D5!$W[O_XG.OX]33+L6DR5/EJA:0YC."B:M=
M=O#K 7Z?,1-[[G4<OOSF>X3SHA0034^E$OJ4(?L2PA%I,^QHR!'=F%Z>FKHB
M'D/KMBUPT"%[N33!V0A_,W_!,%8,UT[8EQ"-YN'XXPZ4]E61,^V'*\3X\)XU
M5N:]BSX)YP%S9L_##3?<CV?$)CO8]>WV1C!PLIZ),WZ:^"NNN.HV_/+SKU+-
M$14'S4([+/8G2&V#]ZP3%QEJR?WIO8E?L=>>.Z!)DT9ZGIF(P?()7'>S81B&
M41?Q;'+/GETP9J/A8J,6ZWEN0YO,<A%_-:\ DR=.PEEG78$)$WYQEPUC%1,H
MKX\^KN_L.P<XVZ%WDPB:-VN&HXXZ"(BY=Y&X+'+-ZXP+-'*+.IDBY)X$))%H
M% OG+\0MMSZ,N^]^S"6F8>'X99@#Y9,CG'G697CZF5>0B,5=M=9X&M1O.TNW
MH7J,R+P^8,/7A83"V'__/5!0F"\)3B\8]1M?5OE36E*"3<9L@/8=NR,I,F[+
MY@>8>!5VVGE;E)44RXG7EOWZEEUN3!X,.FS5231MTA@[[;@%FK=LCU2"=<S-
MZE?+1VPX)QI4Q:KPU),O8NRIEV#RI%^]ZT:P<;[YU.DSL=<>1^'M\1]IQW\Z
M%M)!$/<$)=/<Y%&1F1QH.IR"HSZL_..2SOE%11BQ_GH8OMX ISX\_<%\/FXH
MT.D<PS!J)ZU?O/VPH?TQ<J-1^@!'+MAE%QO+?;(SQ1MD95&$./!*G1L.X9?)
MO^&,LZ_ T\^^*GF9CQ_T/VO4;VA769GN+!Z/X>RSKL#[XS]!0NO7/< 12K)_
MQ>_<#P[./OKWY>Z-KS,[]/!_ZP1&/^Y.ZLYLJ6$8AK%Z47/CV6126%B (8/[
MHF6[+DC%O=7+<Q:^TDB*1\J',2\?1/CTLZ]PV']/Q?<3)GIY#&/5$:A)!C5]
M^.I.O02!\CM/&M6NNVV%=3IV$(?86^*KQN<"2SJPE0! ;YH=:1(.1Z.8.7,6
M+KSD?[CK[D?UN@N>F3^K<+(4=TV6<\E8$V@%N$#.K^9J'1DI9UQOOO5^W'K;
M8UBT: D??-3:3=58WC*('2 ,]%.TKJ$(2@H*\.^]=I%4=@8)P;O=G(2ZW T0
M $.']<&(88.E;BN].I9T.:!)4+N@_YB7G2'<&W46=N"&$IEZY$[JC:VWI*P,
MAQRT)_+S\R3577/U*JZ-['QY,.HS7KU*.^W>O3,VVFB$M_2=!$DZ02Z[#;/&
M_32>![MST_EQ>J!-@[Y<52*.IY]\'B>==B4F39ZFE]732X\JLR4M;?1LX*,>
MH%7DZE$[[_4\A-]GS,*>>QV)M\=_JH-;Z?9 N=!,/)>]G+LC^>T- @0;;\4&
MWFL\AC9M6^"(0_?6.% +POWR?GMXZ?PQEL9*Q:B.TR/LS#WKC".!&'WN3->2
MVA7UOUT?3+"0^Z)N2>M2M@[1''+/U,%,_?J+[S%NW/5X_X-/_<NZ"[IO4I])
MRRD/TB<><J[)]*<HU_*OHJH*QYUX/IY\^C4D$DE$PF%)=K;6EPW?OW)U7[^A
MWZEW)_XW[XOWQ-L;.6HD>G;KX/D?W#@10S_!7SF/E8)A&,;J0[TNL;G9NK9[
M]PX8T+^7N%Q5>LTS2FEHF9UU#C;ZL(%W^^J6J(\:PCOO?(2##S\3WW_O5C2H
M61:^[^+ZD'*AI(Q51: F&2P?UV5$Y[=UJQ8X\B@N[;=$&T^8Q9 .$G.!FJZN
MZY2<-.EWG'?!=;A;)QJP3)QX.,4BFWS,5S89>,YW#9KB6:N$_%==R&_=<0(-
M!Q9<_7!P_<$'G\&EE]V,F7_.UO<$ILTP ^6@([?()VPHY]MLMPG:M6_A$KU.
M J/^D]%-*;1NW0JC1@]%?E$)DG%)I]/)AL'))AR=8596/45@*9UFU#6X)+PV
MT[2=EGTLB:VWV03MV[9T=9MNR/Z>9!\;]1?Q1:3*6[5JCMUVVU:J-:+Z/!5R
M04]VV_</F99>*CV@U+P]NFI\)W15(H&GGWP.8T^]$)-_^UU:@?/Q?&H+%JM?
MKW[-6#NX6LC(--69/X"GO^5\QHP_L><>1^'==SZ1NF>JU'4XD56'N5N7E&B6
M WW=@J(B;#!B$(8.[<]$N<(VD)'YI5G>M=PE=Z7)J(YO?-R>[6S$!D,P>LR&
MS@[15Y/X2NT*C^F#:\8@M:MEW4M(;E,VZAG)\NFG7^&<<Z["Q$E3_,M2#G[Y
M^;K(;UG^N;'683UY54PKHO7BR;&3:[V$"R^\ 7??\R0J*BO$-<V!WC"6 6]2
M"T(.Z(C&EN#H8_='07Z!9O$+)_MWKA-XN3 ,PZAC=.[8 9MOLJ$<Q9'D!+D:
MBCB[[R/(\/6R:=2 \][#"$?">'?\^SCTL+&8\/TOU:PU?5B6#_N,7#EY?JU'
M]K%AU,2/<G(#:0ML#M%H%+OOLB4Z=.HDP3 [X\SYH_)@!^6D7Z;BG/.OPUUW
M/^Y=R5; 3ME49VF%;:PM7!CLD'I2X\#C,!YXZ"F<??Y5^&72-$GSC(7? 90#
M 2#ODW*:B%7@^.,.]LJE^L"+45^AU/NRGI1Z#B$2CF#$B($8/GP(*UU;!I=W
MY(^3=SD7I\D<I+J/#J0FL]HI)TBIT5Z$ _??#7FZBH$15#2XT<Y=Y[N-&CD4
M^Q^T%Q!;+*FUN+ ,GC0[)Q0%6[_7JK\D*12.HBJ>P--/O8R##SD5GWSVC5S(
ME$6VW:_Y'3PWNU@W8"VXX#ZSS&-Z&7^Y^.;;'V&WW8[ ^'<_1IA+4['RU;:I
MTF2NW$:*(R7Z(!5+H&WKUCC\D']GK6)@&,8_Q;<?G%105%" T\\\QGN 0QJ9
MJ"&Q)G+5F_1.NYP3MH6*Q]TK5Y9AW^X;KW^$XXX]#Q-_X40#*0.=(,GR\\N(
M&\N26RZ441V&5:#P0*)&E?$:?5TZ62:$:ZZ]$[?<^A 6+EB",">_:N=]=L;@
MH?*J]^G*AEN7KEVPR<8;B,SG5K>R81B&47>HV:>1GY^/08/ZH6>O?@!?$TVR
M_%!FSP6_-*P/(63N-7//$;7;[[S[*0X[[!1\\<5W7KK+DSW!P$\C?E]1S?(V
M#)^<] 8YR-JZ=3,<>=0!&@P;A,I"MF@8DR=/P7D77(M[[GW"NT:%0E'Q%9(+
M+K@YY>R68#'6)NQ@YA)]7L<R V -]D)XX,&G<<ZYU^*GB;])%BXR+M=27,;.
M,PY>9T>0\5<QV'++,1@TH(>7*LCMF^C6=[([?SAQQ!WUZMD5HS9<3XXH\ZY)
MN'=%R@GWV@/J93;J+'R'N._4IG66_%M_@U$8,J0/(CJX9@055^<\XJ\DFC=K
M@CUWVP9-F[9&*E']'7M.3JCKY;=D]\0F)^"].Y//]A&2=A%%93R.UU][#T<>
M>1;>>OL]EY'V7W2?'QCZ;:OFN5$W<)WVK"_*.J?5N/IY\ZT/<>!!)^/=]S^C
M89,4]>SD.B?7,(?5(XN 99%?F*^3#KF*@9-S5U*&8?PSLNT'^Q V&#X(HT:/
M1#*1$HWD^6ZBP^C'A=E7H'8\%W#ZF.7")\5BHK]?>N%-''74F?CZFQ_D"O6/
M*S-&(\298#7B/##6$DZD.5E/SU2&V;>BLNS'C+*[YMJ[<.EE-V+F'W\@K*]C
M9%T&O_Y8#LX?D;OEP$55)8X_\6 T+"MQ&0S#, QC+:!F6HRWWZ=!^O7M+G[I
M<+FPQ%U/\KJ;_$IKG=09L,'V39V/GO%-Z)/[:#^#7&-_PFY['H577QOO76$R
M/Y/YG(_S ZI_IV%D0V\X=Y!VP*; &?9Y>?FZFD'/WGTD&):&EJ6,<A-1%KXX
M<$6#25-PSGE7X^Y[,BL:9!1V1N%00;N]*9FU#PV&U"&K1"<.A' _)QB<=PTF
M3OS5JV$)"CG!0"<;N D'N5%U<O=B4(\[YA!$(D[.LQT0HW[CZY_L.N7LU?77
M'XRN77L L83*/CLX^<,N(ZO_^@%7V-$ 0.RV.K34<?$J[/N?7="@09F7RP@N
MM%%N(J.S5R$,&M ;N^VQ'9"0@%%^7,>OTP$:^- OD8T_0<;I/99 #7WFW7LX
M')&R2.+#CS_#?ON?C(<??]'+X'_6H>V*Y9;U':8?ZP!:!5X=>Y,->'S9E;?A
MH$-.P2\__PI$Q(^K49<ZX*&?,VC[6[=N@<,/W4=7,?!C%L,P5@TT%<Y&AU!<
ME(?++S\#8GI4 U$?,5VO:UQ:?6)@4.&$9G?@.G.IDSG1X-57QN/0(T[',\^]
M)A<E#WT7-RM,3DTWU1WH$U%^Z5VY_A1=G<-[*(,K&%QRV4V8-N-/9V^YVA ;
M0@[X36YU,4[NEC*1WZ4-2['+3EM).;B^%<,P#,-8TSCSZQZB]/LX:*\:-VZ(
M42/70Z,F+9&,)_0:[15MNO9_^/8]P/A]//Z#6W[Y*/1S(F[5K9^^_U%]U%MN
M?QAQ*2O:><U2BV]3[3L,HP8YYQ%R]JUK:$";-BUPSCDG2,R[6)2-ER&'H:Z@
MNM"G?25HFO3K%)QY]I6XXLK;="*&4R:^DF$9N@Y/HZ[ ^I  6*LDC <??!KG
MG7<=?IHX6=+\6?A.T+,FL"'H2TH3WGJ?WETQ>M10GGEILG?_C'H/]9+K%&(;
MH%-)1FZX'L9L.D(N><NW:A[)JVK,:KX^H $ VZFH+K<T)U!47(RMMQRMR^<;
MP<;%-5Z[U3:;0I,FC;###IN@4=/FXIM($.2U:9V+4DL@%%1XORXXYIDKFVRT
M+*3A<++!Y$E3</S19^#,<Z_"_(4+O1P.YQ.SC#,Z,?O86#ND)\FDZQ<XZ.!3
M<<DE-^%G\>M"T8A<\^K=\^VH)UGM;D OEZ&M2**HM!B;;SX2ZPT=H,64@V&O
M8:P6?%M+4Z&F1FU&& ,'=,>>NV^'9)7332E.+$CY*TYQ-8/@HR$(=3-O5E0.
MRX:#T8E4 A^\_QG.//L*//?\6Z[P5+?S [E1-O4##D"P>J1>V$?"3GA6DZ1?
M>]T=N/3RFS%]QBRQMY1KR2C7-;]GIX.,FT#CRB1568DC#M\/C1J6NHN&81B&
ML1:HO=^"MCLD?FE/#!TZ$$A4BNER?8DA\4M#87I=23D.MNW.^.NA]"H&Z?*2
M\F ?>5C*(IR?CU]^_@UGGG8)QIYZ,18M+G=9O+PU^]AJGAN&3\[UMOA/Q+&Q
M1")Y&#-Z/0P=MCX2555>CEQ%%$R2'0$,'%A ['".8,IOTS'NHNMQVEF7HWP)
MRXA*QE=4IESJ'JY)W_? 4SC[W&OPX\2?M9XH]WP"F*L7L!-:?VEO-)??#;X:
M2,9C.&WL?U%08.]O#RI.%7D=/2KD0%E9,88/ZX<&C9J*#(CLRX__#DEM%\$7
M_7H/+0YUE__*$XBM/NRP?Z-EBZ9ZS0@RK',&0VS7.IRNJ6RW&VXP%$<?=2!2
MB7E.+G020G72 51 41/N32QD@.QT8(8P_3C9<PTC!H[3IO^!:ZZZ'0<<.!;?
M?#?19?)85@!IK#W2\BN[GWZ>C,VWV ?W/O X9L^>@W THG7N?IC'U9MV'O#)
M2OKR.8W<?ZP*[=JVPJEC#]-5#%Q!&8:Q*N#$/]]<9-O:J.BFDT\Z#.%(0IL<
M\_F7<\6^:&PA]ZR=V'++[NEOKB(H=CJ<PE=?_8ACCS\75U][!PM(,LLUR>=\
M'-<!;-0%I")UI0(NBA/'\2>.PWGG7X?ITSG!@/7&RI4\4H><1)*>&!A@.($F
M%>83CD"#!J4XZJA]I<WGF^]H&(9AK#6J6R">N7Y#^E]=UNV(;;<= T0B8L-H
MQ/B/>6C'N>4.+!-7+EZ_JN#<&8X3B2\C9?3'GW-PRZT/8J>=#\&77T[0/"3;
MUR<USPW#AV%0CL&&Y0(X=LXV;=H8X\:-E3-1.JIL<A5V5#)0DE*@PA!%PPY,
M*IJY<^?AANONP)%'G:&=U,SK@@DJ)[?/Z:*K8YQSSI4X[?3+\-,ODU7Y1Z2^
MB+X<@4N/ZZ"$>]J;=:Z#% &&9="W?V_\ZU^;59-3"XB#!/6ZWZM'F<ZP_H@A
M&+'!,&D %5+GG&S#/%P DW(O;< <I/I%.(I_[[,3\O/RY238NLM@V^26W4[9
MND,H*2["5EN.P;K=!R)95:%IJ@*R8&=HD%$;[A>+&Z%PAYI(/TUVFNR.0])F
M%BY<C&>>>@5[[W,T'G[D:7Z)?L;']&'=XZ9;'\ ..QZ,5U]['[&JA/CE8L>D
MGG3+#N,XL4#2],GA7 SOLN!DBP9-FNH3U9TZKN.E$LJ[V0W#^*=H!Z4>U6Q/
M8?3LT17''W^(V.:X9(Q*J_,&V;7/(.@VAG=+'<Q[38D?0IW,V)N]3)S6[YY^
MG_CS9%QX\8TXZZPK$(O'O&+AK]S6W76%;%]HQHS9./*(LW#+;0]A]IQYXFN*
M[*OK)'7K96/M^BTBT+"?,"GR'*O"84?LA]8M6S"Q6GD9AF$8QIJ"UM?W1?UN
M#;^?G_W#>?EY&#*D+P8,Z _P-0"T5QP/E"R,I#V#GC/X$PS\50W\<3VU[Z&X
MKI2X:%&E]COLOL_1N/;:6Q"K= ]DUQP_X2KQ^EG#R")'(QEWVW2'^4Z6H4/Z
M8,<=-T6JBHV$"H<!H7.6V9!RIMEX\0%W&BM0X<K&B08+RROPX -/8;\#3L3K
M;[SO!1/LN/9$*,>4\^J#RCY3EKXB=WMG"-+H"$HFK;P\CF.//1_777\OIDSY
M76K'!7U\:H)0JN6+I*HDG9LF9OY6O4;N)ZD.@]Q7DJU7Y%)E-(F$M.M33SP8
M146%+(0T%A '$]9J=LUVZ;0.-AZSOBC[B+8C/EGDOU=3GT QZCS."HL&2R0Q
M8L1@=.[<6I\B8H>M$738FOUZSCX&!O3OB:./W%?:=4PEQ)]4H-:-YJZFS0P<
M],&X9PO1&U:<O\!-RD&5(0=XG%?+)^#CR02^^NI[''O,63A^[#C,G;^ F026
ME_<E'KX/PO3,L;%B./E;L7+CQ$_&(!EF_#D7!QQT LX^^VI,^.87J3RI06Z,
M4>2K*=_59%S\.=:QNNXUZC'8N)5N>,=:UBP L17=NW3$T4?O[[*DT5;@#HV_
M#4O/,(A.[%6!6+H]Y>6%<,+Q!Z-UVQ:2Q=.#TBZ3HKLB@5=-C+&],J%.UF+R
M=+.GEW7"13B,63/GX)K_W8-##SL%/__RFUY36^ =I5E.F9E=_OO4++/,V=(^
MT-??_HA##CD9]]S[.!8O7J)]8BKS4J%^O?H$R>[J<M)>/XI"O\/;,[6TK$3\
M[_]H/ZIUI_PU5D2&81BK!UHE?]*]LT=R7N/)DX']^V#[[3<6&Q876T9KQM6<
MQ:[YMBW'H!]4<RS$C1&Q5*0TZ>K(]1\F3,2YY_T/N^]])+[^[J>E/J-.KGS.
M^0JN7X+^0YI<+%RCEL@PT&0ZXS(!1E(=Y7/..@'1@CP-@(GVXZF"8C-SQ[E,
M.)*'BG@,K[T^'D<=<PYNN/%>Q!-QZAZ!OVJ6CU/>W//(],ORR<@CFZ1?EGQ*
MT77L.X7.:TZ&]8D(-9ZN"7/IX__L?Q1NN^-!S)FW0.J+LJN7U'@&'BDGFD2W
M5#"?9$_(L:2)A=QBJXWPKW]MX67,4+.3P0@F7+IUO2']T*=?'Z025=K1J5I=
MVH]J*).#N@V=_Y W^)98@I/''H[2TC*IM^H#<D;N45B8CRTW'XF--^4DT27:
MMIUU),Y_,Y:&@QM\&G[&'W-QR\T/88LM]L7#CSXO5[+]#_H>"2E#SX]CX"GE
MF=:7IC97&+_<LFU-YE#*E\<:U#M_CMS_X%/8?-,]\/!#S^&/F;,1YIN>PIPL
MXKZ//L^RR1&Y]WQ;)Z<<Z!"YEN M&4NB:?.F./"@/="T:2,O#\O+^<_&RK,\
MJ3-RC>7KF9;-F^&LLX_1E8:T]4E\QO>YNU7$<AFQ!> *#U*"T1 6+%J(!^Y_
M#@<== K>?.LCN:[=WIZ-\/166M][YUED^SD6SZP([%-A'?#'D3&GV3X0\.##
M3^&@ \?BA9?>0D557.P+,^9&&:LMU66EI4RR^Y%8=K$*7'#A*6C3NKF4I2]W
M9E^71VY(C6$81MVDL+  HS<<AAX]>P$Q\<'8#ZPK0HIVSC@!1MH'HJ\DOD D
M@CGS%N.9Y][$'GO\%^,NN@%SYL[S\C"W^ 3T ]1_$O\UZ?=FT">@_ZHGR\%\
MAR"2Z='*(>@,NZ#,-08ZTCUZ=L;YYYXH2F>Q-(:D]T2<R^<>>LUUY>/>W<^.
MYN^^^PGGG'<=CCSZ7/P\Z5?ONB@8_S%"KZC\8)<E_9?Z)<?Q.Z%K(].!X,J7
M^=@%X:?><LN#V.??1^.IIU[#XB65.GC 819]7V!V8!A@4FRD7,% RLHM4RDM
M6^X_7AG#N6<?BZ*B(DTC:;E,EZL1=(8-'8"-QXR0RG?Z79N23K/D0>WMSJ@C
ML$.+R\TF$^C<95VL/VP (I&HM%]J0:<3C=RE<^=U<,3A^Z"HI$1DA/) OT[:
M-.5F&3;5<$0B>2A?O 0??_(UCCWZ+/SGP),P\6??I_,G:; \95_37)KY_&O2
M*^6X3HQLG\--WO#E5> EN?[3+[]BQYT/P4DG7X*OO_H12RKC"$=Y43XO_AQ?
M@.4O;YCKL#@YP4"?I)3SI!PGI<PC>1&L/WP@]MIS>Z9FY=5#TPN&L=J1-BDZ
M;L_=ML/(C380VRQQJ_ALVO:DO>8V(2F"B.HDI_=3J(Q7X9WQ'^.P(T[%)9?>
M@GB,-H-YJ:O\C#[NN*8>X[G%M2N&3IK4'SV3(A4[P?+TBC0F\<999U^%D\4.
M?_3I5TB(76'?RM)U$3S8E:=RE)8GKW_*:[9<-:AK]R[8>\]M=<(J83ZSJX9A
M&$9=9IC$AIMO,5+LVT*)#FG[:>,87[OK1NV$(A$DQ(__[KN)N.R*F['=]H?B
M[KO^S[OJ8O"T9\3)F'I"_\#S^Y?;7YOK,4$PR;%:S3C#).,0IY"7EX^]]]H>
MO7KW03*>@#X1)T&'_V2T-],@AY$RTS*1?Z)H9LWZ$_?<_1@.V/]DO/#"6WK=
M+4O#/"Q7_YR!!\O.+VMC6;@@+;NL6'ZRI8O.G?OR.WOV7!QY]%DXZ[PK\>57
M$Q!+\%V];DGX<$CV_"JMBQR17;E75S(JI'K;N^ZV#88,[JVIA&53,QC./C:"
M"5^5,7KD8+3OV-6](U;;4/9FU&74EL0KL<MNVZ&LK$12.)'(.K4,KE02Q>A1
M0['/OW<2&5FDYE*E0NP!!S6,99,*BY\68>=Y"C/$IWOHX6>Q[0X'X/0S+\7<
M>0LE!\O/Z4=I;=+>^,2XGF;<$F/9>!,)W&I2-671^7.*7%Y2&<.QQY\C@?N!
M>.[Y-S%]^@Q$\B-\T,+S^>0@Y8+UFCY,KN(FTSJ?EQ*I@YBQ&-JV:8WSSCD>
M9:6T%2PWYO9C$I8G?^>(7VP8:P&OR:%APQ)<=<4Y3A5R8-=TE\*)L^Z FQO
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M\"FFSYR)Q>*S+5Y8B04+%DIL++& Z+!0A,/>&?1)?.__Y:,3J 3]KU2_9-2
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M"Y'EQBW3L67D&D[?4 :RVVJ5!,1GG7TE+KGX.H3R"CQY,=8.U/_>8!V?H$D
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MITQ'+![7O\.)(945,4R<^ OFS9NODPSB<HWO (S%9%]9I:\]8 "<DKU\2(5
M/\MC8]4C[<M_ZC1558F[[KH:^^RSH]:_82P/7_=FMTTFL:/RECL>QLEC+\3\
M>0L1"D=T8I!3+1P L;:\NF%1^Z6LQ2Y.X%Y[[XB;;AB'LC(^J6H8*XL_ ]I)
MV*)%BW'I93?A_/,N!_)*G+V6'-SS/7$,&^5$\^IO_3!_&8:QJF&[TR<0.-%
M#7(M;<WS^SAQ=]UUU\'CC]Z _OUZ>>W:6-W82@8VR6!UX\?W'W[T!3;>9$^4
M2WRMMED[<.F/.]V@KSGB4^LB@+Y/;ZP:6)ZN2.471S"DC*-YWBN,HA$4Y+%_
M):KONRW(S]?\+5HT1\=.'9"?'Y&/L),]J7TP'3NV1XN63>6[(OAU\A3\^NNO
MB$3SY)LCB$C]39_YAZ1-14Q\_2K9V._"_A3M6ZFH1"7[5R0]6]FP+\U834B=
M:/TG8VC5H@7^[\D[,'1H+RUZ?1>U5(3?#KDW_AI;R< F&1AK#IMD8*Q*)O\V
M'<<=?R[^[_'_0ZA 8A_:/EUQFEK<@VZ2VD[.DN>QYZL:=1:;9+!FL4D&?P,^
M9</!9P937WSQ+;;?X6!]JCTL 1:7]V-!4EQUY0)5.AP,EV/9V22#?T9V@).]
M=\=2_"QJ5?A^.4N"%K=<EZ"8*QYPPH&<,5&O<=G=? F6.:C(][,SV-5+_![Y
M/(<<JBHDC5\NAL1](2T)=^Y[TC/<C-4.7Y&@=1M+XL #]\'_KCD+A<7Y6E-A
MV Q[8\5P^H%-V+7=+[_Z7M_!]>9K[R!<4"CZFEI"?L(V,W5-XFE7)*L6X,67
M'L6FFXRT"43&/\:7*Y]9L^?@G+.OQ W7WRCMO:EDB$MJ1-N\Z@:U,_()U0]I
MC\$PC%6--XBH$PUJB9%XIN]@%/^\2?.F>.R1&S%ZU'J2QLE#[AV-QNK%)AG8
M)(/5A9I;%2;75Q)+Q/'(8\]CG[V.$9/,AP1HF\4']"8:Z?M94S&+]]80U++Z
MCXT^6S?K8=+UK13P27=6HM/EW'/205Z4/E5$5Q_@*E+$31 )H8J3"MC?HGTK
M\AEN\IW^!&^>9B^EZ\=JQJJ#GJT_68?'?"B*]?' /3=@UUTW032:)[DR\9=?
M#[:BP8IADPQLDH&QYK!)!L:J09T;L7/ \\^_B>-./!<_??^S]@UK8A9J#UD1
MHM6=;:0_XZX9=1.;9+!FL1[\OX4K+K[W8\" WKC]SBO0I$D3$5KGI&OG-#<-
MF.F]2Y EBH?CT_IN?6.EJ1EH^N7I9K=+L"314B0:UK+F%I;@-RQ!;C@:U<\Q
MT%TB6V5E3&?)\WS1XG+,F3L/?\Z>@X4+%J-RB:1S%GU%A>:+5;I5#?0[(O+=
M\IW<\V\R4(YX?YN32K2^C=6&UCUG$8H<;+G5QKCTDI-06,Q51%C^%O :R\?O
MK"*^'O'/>_7J@E$;KB='<7'<1<^(+@F%^=04.UZL7:\)5+^SS&,)C-IH4PP<
MV-,F&!BK!FWF_"6;_&O>M F..FH_;+WM=DA6SI5TREE2)X]R[_L:SH\SO\TP
M5A?:SJ2]^1,,?-N<(81$+(:&31KBJBO.%#L])&V1S3(;1OW&-7?:6.?K1<-1
M[+C]YKC^NG% ;)Z7+M<YJ2CI?'CVOW#2@;&:X00PB;G9OQ$1_<S^%-</(C40
ME2WBXNZJRC@J*_R^$]DOJ<2">8LQ^\\%^///N5BX<+'VN7"5@LJJ"I17EB.>
MB&D_2B0O3[^'>C_L]ZTP_I)S]O%H?6L_B[,5A&G&JH Q+OLN:4NEC54MPOGG
MG83MMQ]3;8(!R]M-+'#E;A,,#,,PC"##D85--]T AQ^Z#_*+BI&,BXW,\CO]
MV)7C31J,BGE<.GXUC-S&>9'&"J%ZA &.'(1%LVP\>BC^=]V90,*])RZ4E&!)
M_?"D*AX-E!*^8V[*YY_@EY\_N<!7\%H?.AC(@(F=$9*/US27@WDCH:C4#P-F
MN<[@62K(#UY9EZ&(?"+"S\LYW]7L?8_[+GY*@F YEA3W-]/H7]:]L?I@U7(Y
MZW7:M<?55Y^.)DT:2:J3!2MZXZ^@#LC6&?XYR8M&,7KT</0;. #0IVND1:MH
MN>O&ZD7U*0VF3B*JPMY[[H!&#1MX5PWCG^%L-LT$[3F-10K=NG;&A1>>@FVV
MVP')JD5B220][.10)ZU11_#'.E0-8[6AOC,'$#V;[!)EKSZZV.M$$B5EI1A[
M\N'8?=>M=>*9RV>AJV'4;[SX3=JR^H TO]*TBXL*L<^_M\/)IYP@MKE<KHD>
M"'&EDSRQR,PG.L":_^I']+*6L^IG*78&17+ I]]UB6!>9(7)%N+D $XZH'\5
M22(493\*)PZPWT2NT8^B3D]%Q,V*RA;Q8GK^H<SWR*?=P#?_CGRGV@#^<<&W
M$6D[8:PT+$.N!B1'NB6KEN#PPP[!X8?NB9*2(DG+-#!.+C";:QB&800?S[\0
MNU=0D(\##]@-^^^W*Y"H%!?&]0O1EZ%;XOP39A:?11\P=KZ*81@.\QK_#JI4
MG!JA8N'@U/;;;8[K;N"L^TH=F J!3\Z[]XMJH"1!%A&77O?&RN&7IU/J7MEZ
MDP384<D9][J$8I*!K AV5B#*)6RX%%R8$PGDHJL3?H=[_07-AKYWCIL<)Y,)
M_9Q^D1J.N/X-'__OZDQ[V?/SQNJ%-94?CN"9_[L-W;JNJRE$Q$!D0@\-XR^A
M_G =)M59?_@@#!TR0 1J"70E ]$+VOR]Z\;J0SL@A60RA:+24FR^^0;(R^,J
M)8;Q#Z&!IH5FNW='\EM:M]CPOKV[X>BC_X/.W;H#57Q5DO@!7#+6RT]H7PS#
M6/VH7^^[V6)\$^)?%Q3D8?]]=\;1_]U7.WP(\QF&4=_)](FHO:7)U?:?1(.R
M,IQXPB'89]_=D8I52*/G(+6+RSFVS8%H8_5"7XDK 7//TO8'_>FG)Z4NV"_"
M_A$_G'(/@,B)UI54$JM4ZU4^7<O&?AC6)9^25T=+-EYB/PX_Y^MY'OOGW/0[
MC7^$L[6N_:6JJC!ZH]$X[?0CT+1)$ZWK#*Q3YG-YB=E?PS ,(VCX/H9X';+G
M!C1HT !C3SH,V^VPM=C*!<X^TE'A/SI(AF$LDXSG:*P@$FC);\8Y5$ E)<7X
MS[]WQ?^NOPA(E#/ZU8XR75I,2I>!EP9(WJ"H\<]A>3+@]0-./9;RYKOY.9L,
M80;'4OY:[K0%K#'F=\&I&A(O73^C1UXN^0Q?@Z!UK#/OW>0%SL;W@RM_+UGE
M%RO;#4P8JX^PE//#CUR'OGV[25%G E^M VM;QM] VW^-MEQ45(#1HX:B99OV
MNCRSKR&,U8]?!X@MP9'_/0#-FS=5O6X8_QBUT3QP,N:DRK5M^@T;C1Z.:ZX\
M!^MVZX)4987FX&L[U"<P&32,U4JM;8R^O,11>=$0#CI@=UQP_HDH*2[V+O(S
MM-_>B6$8]1B)O]F8M3UST)I[URW5O%EC7'CA2=AHHY%(595+"@>C.<B=U#C=
M6)U(A803X@LQMG;QM;^TO@NZ.0V;*W=*74DB4]AOXE9[=/TI?K6F)$T_)_ J
MZY!'_#Y.).,J"/Q.GFMOC/:I:$Y%'^:0:_37"(_--_N'L$ZD'%/Q*JS;91W<
M>NO%:->NM;NDOY?N4Y'L@NO/- S#,(P@0=O&S=DZ-9-""AT[ML6))QZ"(<.&
M(UFUV+.!S)2QA?YG#</(X+QV8X7P0JPT3J&$4%9:C+WVVA8GGW8T$O$_)9TK
M&3 _ R@>9P(U8]7@!YH:*,GFO\I 53\#5R\/M]KP38$:!N^89'\FVV L]3T,
ME"7 YBLRN/R?-:75!Y?,?/31&['UUIM(G; #@T\^LSN"&[&R-U8<;?/IMDT=
MXG3S1ANMCPU&#*7 2;)(EBZ?7E/K&ZL<]C&RE"/YV&V7[5!<7*C)?NLVC'\"
M+08E3,5)[7A&KO+S\K#%YB-QU95G8-VNZ^I376XRHN2ID=<PC%5+>N4"#WU*
M6?SW_/PH#CIH?XR[X$0T;%CFQJ44#CC1?GNGAF'48]S3\3I9GW%=5COGUKYM
M&]QYUQ48O?%(<<O%-C.K?$:??C=6(Z)C$U(?":D?/FC!<J]%Z6;'4K7UM_ \
MQ,T[UU=::MVZ?/RL]M=(GNP^'&[^-V5_?_:QL?)H7243:-ZB,>Z]]UIT[=)!
M4EW9NH+W^U2X=T::16_E;AB&8009VCKG:GCV3DY&#!^ XX\]'.TZKHM$I;?B
M;=;0 UV;FO&L8>0Z64W$^"O\ *<V&C=JB&./.@"''GXD$E5_BFJB1^X-@JOS
M[@73C)+3/69^P&6L#-D!3_:Q7T]:ZG+LEW9-F.YOM;'<@(J#D-[&P6[)[=*-
ME8>K1<A.RUWJC>V&[PH\]X*QV';+T3H@I"I+*TS:DVZ&L?)05?#]HJ1-FY88
M,J2/#G;K,EC\I[K:I.R?X3W](F7)-NN33I,M&8]AY*BAZ-BIM4N7S[C6;?;1
M^&>D6R\/5+8H@^E4Y.5%L>7FHW'U56>A2[=UQ>94J.WA#Z>S.47@Y]?I,'+J
M^77Z?89A+ _J=-^?SMB I+8CMBW7.9/4)UOS\O.P^Z[;X*(+CM$)!B33RKPX
MREAK6.D;JY[J-MF="Z(>.G9HC;ONO *CQFR(E,2#FBPZ(TR;3-VA*4+:1@NF
M(_XYV7T<+&3YQ5+U-T*=OJQ^DNQ\/JJ[O;KQKV>G^2SK.Y>5;M2 [2)$^RJ&
MU2]OUJ7 6F1\VZI54SSQQ!T8-K2OICMJB[>R8S;G$1LK1W4I-PS#,.HNZJ'H
M[V@TBIUVW 2''+@KH@6%2,3C<*_6%KLJ-M;96NNO-(QL,MZC\0\)H76KYCCS
MC*-PV'\/UW>WN.2$*B@=,.6,;8VEY8R.?RHBSKX+KJWCS @ZV3+.XVHRSX:1
MBHM"XE,3WDH@5>4ZP>#X8PY"?KY['Z]AK"["X1"VV&(,1HX< <0K79K(*)_B
M,58>=DRE7QN4U4FHQ^S 9,=6LA(GG70X&C=J0&.9A;DHQNJ'$PVVV'PTKKCB
M+'3NUE5L3Z6(H:Y%)?(H6SIX]#K:Q6_3X0V+*0UCF7!" 2<0)!->S"-HJ])C
M;Y(HXR%1\V(BF!$CA@[$U5>=@X8-2GG5J&-4,\^&L=H0I<"!TE08'==IB[OO
MO!P;;;(!DK$*20\CR4%3KW]%!U5IC.EC,L4&HXU<AC8U&9%VP'X5M@5I1^QK
M9#OAJ<2WEUUQ-H8-Z2]Q+U?B)#3 ;'/NS%CUF%8R#,.HGQ04Y..X8P_"Z:<=
M+<<%2$E<JW&L[/BPE-I;H>;X1LUSP\@57(LP5@D,<MNV:8XS3^-$@X.1JEJH
M3GT:"8S]019_@"4<X?64]R2/8027F@.,_KL6W3F'<R+:AOB3F6!P($I+,^_C
M-8S5@Y/#?GVZ8_BP?GK,Q0ST/:19<FO\?6C;.'$H/<FN!GS_=I=NO3%X0&]$
M(OZ2N<QH1M%8_;C7I:1THL%66XS"U5><CG6[=D:RBA.-. !*@?3\N+0_Y]+<
M.XL-PZ@-^G.,<:CWV<G"IL8];8%O#-QY"M&\?!QVZ+YX[-$;T:1Q \\B&X:1
MNU!QN*..'=KBKCNNQ.A-UI?XD*L-$<^AU(E*[%_AB6D.([?1IRJ%4,I?>4#:
MAK2C%.) K IWW_,_[+S#YN+S>FMU,<Z5/$EK.X9A&(91"RD=CSCBL#VQVZ[;
M 4FN9N"/8XB!51M;?6R#J'W-.C>,7,&+T(Q5@5L&-(4V;5K@S-./QN%''"3!
M\")UVSG3R:D?.>:,)NVLIN+A3'Q30$;NX,MZ.)Q9^M;_S2O5)QB4I*\:QNK#
MR5@T&L%ZZ_7!.ITZ HFXR*?IY7^*#BY)F^=@$_=^FT\3K\2NNVUI3ZX::P5?
M/HF^.F&+C7#EE6>CL_?JA(1<<Y=IG]SR>$XO,)ADNF$8RR*9C/.WFVS&@4"=
M7\!8*8Z(M*E$,H2\_'P<<N#NN.2BD]&L66/-;UZ?81CIR::I$#JLTQIWW7X5
M1F^\@<2)52Y=$(OL;+BN;&!&V3 4M@?ZMW+("0:I6!)WWW<-=MUE"Q05%4@J
M!T-<'B+66?>&81B&860C=E),9(L6S3%NW G8\]^[:/\E7<]46&QIB'%K*#VV
M09_4[ULRC%S$)AFL2E27A'464YO6+7'FF<=B[.G'2C"<D$M)A+ER@6SI@19=
MRHQ/;XM2TA4-#".X^(&LO_>-KY[+)B9:VLH2G'O!*3@N/<' ,-80^D0SL,U6
MFV*3338$E_#GNU^-?P9M'V?9I>V>)LI>-JJ X@8-L/]_=D9Q<:%<T'5,7!YS
M3XPU -NXDTLG=_Z*!E==<28Z=^D,5)5KX*@3#,+<>T]\R;]P;4MS&(;A8-M"
M5/;>$Y6<G".;#@1*_!-/I)"?E\)!!^Z*BR\\"0T:^#Z?M2O#R&V</^X>WM #
M(:PK&MQ]Q^48O?%P76TH!>H6ZA1>Y;$-E1JY33@E-I>V5N!O[6NI NZ^YRKL
MNO/F*"HJDE2O?86<;4Y/SN$2?H9A&(9A5,?K*FK?MA4NN_AD[+7/KDC%*]PD
M>OEA7Q+MK=_?F;T91JYA/3FK$D^'<!83:=VJ.4XYZ;_XW_7G(A6K0"+.IWC\
M@)D3#_Q!%RHD/B%G&,&FVD"CP&-GD.6:MX(!)QB4E99H<)S4)T<-8TT@NEF$
MCH/=PX;V0\-F+9%*\$D/ZW1956A;]_JR=.)!/(8=_[4EFC=OYND%==/ULME$
M8TU L5/[HV?NMYMH,!J//'(CMMQF"R1C\^521+:,RYRB[?+R&X91"]Y A^IV
MZGOOJ4G&0<ED")%\J+]WR;BQ*"LKE>MLC/*/=D(_:1A&;N)LK>]^<[(J#WG>
MH4-K]^J$C49(W+@08>H4T2T:7^KGG ]I&+F('[.R+21C?$5"''?==SEVW65K
M%!7XKY]D._']61>4J?W5UX,9AF$8AI%&S"I?KYGRXMJV;5KCDDO&NA4-8I5(
M)CR[RW@W:V]]R$:NDNDQ-58QSFEOU+ !_K/O+KCN?Q<!B7(DDPFGJ.0G%.%O
MYK-93D;P\0UM.@#6CB%V/,M6M2C]B@1.,"!\<C2D3Z88QAJ *MA3P\.']\>
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M:ABKGY*&O5%14>F=!9^D*).&#4IQ\;B3<=BA>WFIQMIFVO29..'$"_#0 T\
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MHOI4#7V]1$H"84ZA%[GG*[&&#>^/IY^Y#7OO^2^4%+L5:U)<^8#MQ# ,XQ_
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MB>-PU17724A:JN>Y4&_)>!P]>W7#<T_?CDZ=VGNI1MW#Z1+B^E.<9+I)!S3
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MY,E")R5XWZ-2ES59@"MOG'[ZI8B)'/ICR+Z_J6-_/.:?E.OL-ZH-FV10IV!
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MCM@7;[_U"(XX:C\4%>0A52GV5"(#[7BF\RXZA1W-].72)M4P5@/4OY117:E
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M+R?5K],V2:<S2$L[IW/'&GSD(^_'HW-GXHDG_HC/??KCZ-^OG\YR9U!_LY<
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9:0' _P+T65Z?N6H<$P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
